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Optical Imaging of Breast Cancers 
 
Yan Xu 
University of Connecticut, 2013 
Breast cancer is the most common cancer and the second major cause of cancer 
death among women. Screening tries to detect the disease in the early stage, and can save 
more lives. Diffuse optical tomography (DOT) in the near-infrared (NIR) spectrum is a 
promising noninvasive approach for functional diagnostic breast imaging. Our group has 
explored the use of ultrasound (US)-guided DOT to improve lesion localization and light 
quantification accuracy. In this dissertation, several special cases of breast cancer 
imaging were studied with the US guided DOT technique. 
Firstly, the heterogeneous absorption distributions of advanced cancers were 
characterized. A series of simulations and phantom experiments were then performed to 
systematically evaluate the effects of target parameters, target locations, and target 
optical properties on imaging the periphery enhancement absorption distribution using a 
reflection geometry. A clinical example is given to demonstrate the complexity of tumor 
vasculature. Secondly, to improve the light quantification of clustered lesions, a new 
multi-zone reconstruction algorithm guided by co-registered US image is investigated 
using simulations and phantoms experiments. The performance of the algorithm is 
demonstrated with clinical examples. Thirdly, the DOT mapping of tumor 
deoxy-hemoglobin (deoxyHb) and oxy-hemoglobin (oxyHb) concentrations in blood 
Yan Xu – University of Connecticut, 2013 
phantoms and in in-vivo patients is presented. Targets of different sizes located at 
different depths were used to validate the accuracy of oxygen saturation estimation. 
Clinical examples are given to demonstrate the mapping of heterogeneous deoxyHb and 
oxyHb distributions in breast cancers. Fourthly, in vivo mouse tumor imaging using 
fluorescence DOT were conducted; this demonstrated an improved imaging capability of 
a new synthesized 2-nitroimidazole-indocyanine green conjugate using a piperazine 
linker (piperazine-2-nitroimidazole-ICG) relative to an earlier version with an 
ethanolamine linker (ethanolamine-2-nitroimidazole-ICG). All the findings have been 
supported with the fluorescence images of histological sections of tumor samples and an 
immunohistochemistry technique for identifying tumor hypoxia. Lastly, a two-step 
imaging model was set up for the two-layer tissue structure of breast imaging. Absorption 
and scattering distributions of the lesions in the layered structure could be reconstructed 
simultaneously. Simulation and phantom experiments show promising accuracy and 
clinical examples were applied to demonstrate the utility of this imaging method. 
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1 
1 Introduction 
1.1 Breast cancer imaging 
The breast consists of lobules (glands that make breast milk), duct (small tubes that 
carry milk from the lobules to the nipple), fatty and connective tissue, blood vessels and 
lymph vessels. The milk-producing ducts and glands are the two most likely areas to 
develop cancerous cells.1 Breast cancer is the most common cancer and the second major 
cause of cancer death for women.2-5 Biomedical imaging plays important roles for breast 
cancer on the detection, diagnosis, treatment and monitoring.4 Traditional imaging 
modalities such as X ray imaging6, 7, nuclear imaging8-11, ultrasound (US)12-14 and 
magnetic resonance imaging (MRI)15, 16, are well developed and widely used in clinic. 
However, due to drawbacks like high cost, use of ionizing radiation, etc., new biomedical 
optical imaging techniques based on the rapid development of laser, is currently being 
researched and applied to clinical practice. One of them is optical coherence tomography 
(OCT), a high resolution technique for imaging thin layers of tissues in a turbid medium 
at micrometer levels.17 Another one is photoacoustic imaging (PAI), and provides optical 
contrast at ultrasonic resolution.18, 19 Diffuse optical tomography (DOT) in near infrared 
(NIR) spectrum has shown clinical potential of probing the tumor vasculature up to few 
centimeters in biological tissues.20-24 Figure 1-1 shows the spectrum of typical biomedical 
imaging modalities. In this dissertation, several special cases of breast cancer imaging 
using US guided DOT technique were systematically studied. 
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Figure 1-1 The spectrum of the biomedical imaging modalities. 
1.2 Diffuse optical tomography (DOT)  
The NIR spectrum from 680 nm to 900 nm shown in Figure 1-2 shows is called the 
optical window due to the high absorption of oxygenated and deoxygenated hemoglobin 
(Hb). Meanwhile, the absorption of water is relatively low in this window, making light 
penetrate deep into  biological tissue.25 Additionally, the oxygenated and deoxygenated 
Hb absorption curve has an intersection point; this means that if multiple wavelengths 
were detected, the concentration of oxygenated and deoxygenated Hb could be calculated. 
From that, the total hemoglobin (tHb) can be determined. Since NIR light has been 
identified as a potential diagnostic radiation,26, 27 and Hb contrast has been confirmed an 
indicator between breast cancerous and normal tissues,28 DOT in NIR spectrum as a 
non-invasive imaging technique, has demonstrated the clinical potential of probing tumor 
angiogenesis which can be quantitatively assessed by the tHb concentration.22, 23, 29-31 
However, the primary limitation of DOT is related to the intense light scattering in tissue 
which dominates NIR light propagation. As a result, the localization of lesions is poor and 
the accurate quantification of lesion optical properties is difficult. To overcome these 
drawbacks, a priori information provided by a coregistered modality, such as MRI, X-ray 
3 
and US, has been investigated and proved to be a practical method for the clinical 
translation. 22, 32-38 
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Figure 1-2 Absorption spectrum of water, oxygenated Hb, and deoxygenated Hb in NIR 
range. 
In our group, we adopt the US to guide the lesion localization and use DOT to map 
the lesion vasculature. This approach has successfully overcome the location uncertainty 
of pure DOT approach.39-41 The current system we are using for the clinical experiments 
is shown in Figure 1-3. In the middle, there is a bed for patients; the commercial US 
machine is on the left side, and the DOT imaging system is on the right side. The US 
transducer, source fibers, and detection fibers are combined to make a hand-held probe 
and lies on the bed as shown in the figure. The center slot of the probe is used to fit the 
US transducer and the sources and detectors are distributed on both sides. The DOT 
system is a frequency domain system with a modulation frequency of 140 MHz and 
4 
consists of 14 parallel detectors and 4 laser diodes of wavelength 740, 780, 808 and 830 
nm, respectively. Each laser diode is sequentially switched to 9 positions on the probe. 
 
Figure 1-3 The DOT imaging system in the operating room. 
1.3 Fluorescence DOT  
Fluorescence is the phenomenon whereby a molecule in the ground electronic state 
is excited and jumps to a higher energy state of the excited electronic state by absorbing a 
photon. Then the molecule drops down to the lowest vibrational state of the excited 
electronic state. Following this, the molecule drops again to one of the vibrational levels 
of the ground electronic state and emits a photon in the process.42 Typically, in an 
experiment, the absorber is excited with light at one wavelength and the emission light 
goes through a bandpass or longpass filter to be detected as the emission spectrum. 
The frequency domain fluorescence imaging system we use for the in vivo 
experiments consists of 14 parallel detectors and 4 laser diodes of 690, 780, 808 830 nm.  
Each laser diode is sequentially switched to nine positions on the imaging probe.  The 
5 
14-channel parallel detection system has two modes: fluorescence mode and absorption 
mode. The two modes can be easily switched by moving a mechanical handle. In order to 
remove the excitation and stray light, a bandpass filter is placed in the light path in the 
fluorescence mode and in the absorption mode, it is moved out of the light path. A sketch 
of the detection optics is shown in Figure 1-4.  
 
Figure 1-4 The sketch of the fluorescence detection optics 
1.4 Dissertation organization 
The rest of the dissertation organized as follows: Chapter 1 gives a brief 
introduction of the history, development and the principles of the imaging modalities 
used in this dissertation for breast cancer. In chapter 2, a series simulation and phantom 
experiments were performed to systemically evaluate the effects of target parameters, 
target locations, and target optical properties on imaging periphery enhancement 
absorption distribution using reflection geometry. Large tumors modeled as concentric 
semi-ellipsoidal targets of different outer shell and inner core optical properties were 
analyzed as well. In chapter 3, clustered breast lesions imaging will be introduced. 
Clustered small breast lesions may be present in the neighboring areas which are difficult 
to resolve and quantify accurately in diffuse optical tomography. In addition, advanced 
breast cancers are often accompanied by clustered satellite lesions in the neighboring 
6 
areas, which are also difficult to resolve and quantify. To improve the light quantification 
of clustered lesions, a multi-zone reconstruction algorithm guided by co-registered 
ultrasound image was investigated using simulations and phantoms. The performance of 
the algorithm is demonstrated using clinical examples. In Chapter 4, an US-guided DOT 
for mapping tumor deoxy-hemoglobin (deoxyHb) and oxy-hemoglobin (oxyHb) 
concentrations in blood phantoms and in in-vivo patients will be presented. Targets of 
different sizes and located at different depths were used to validate the accuracy of oxygen 
saturation estimation. An inhomogeneous concentric blood phantom of deoxygenated 
center core and oxygenated outer shell was imaged and deoxyHb and oxyHb maps 
revealed corresponding distributions which correlated well with inhomogeneous deoxy- 
and oxy- distributions frequently seen in breast cancers. Clinical examples are given to 
demonstrate the utility of US-guided optical tomography in mapping heterogeneous 
deoxyHb and oxyHb distributions in breast cancers. In Chapter 5, the synthesis of a 
2-nitroimidazole-indocyanine green conjugate using a piperazine linker 
(piperazine-2-nitroimidazole-ICG) capable of robust fluorescent imaging of tumor 
hypoxia will be described. In vivo mouse tumor imaging studies were completed and 
demonstrated an improved imaging capability of the new dye relative to an earlier version 
of the dye that was synthesized with an ethanolamine linker 
(ethanolamine-2-nitroimidazole-ICG). All the findings have been supported with 
fluorescence images of histological sections of tumor samples and an 
immunohistochemistry technique for identifying tumor hypoxia. In Chapter 6, a two-step 
imaging model is set up for the two-layer tissue structure of breast. First, a small probe 
with short source-detector pairs is used to collect the diffused light only from the first 
7 
layer tissue of the normal breast; Then, a clinical imaging probe is used to collect the 
perturbation data from the breast with the lesion, and the reference from the contralateral 
breast. With the relatively accurate information of the first layer, the optical properties of 
the second- layer are fitted. After that, a two-step imaging reconstruction using genetic 
algorithm is performed for the two-layer model with the fitted bulk tissue properties. 
Absorption and scattering distributions of the lesions in the layered structure can be 
reconstructed simultaneously. Simulation and phantom experiments showed promising 
results. Clinical examples have been also applied to demonstrate the utility of this 
imaging method. Finally in Chapter 7, the dissertation is briefly summarized. 
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2 Imaging Heterogeneous Absorption Distribution of 
Advanced Breast Cancer 
2.1  Introduction 
Optical tomography has tremendous potential to provide clinically useful functional 
information about tumor angiogenesis and tumor hypoxia.1-22 However, the process of 
tumor angiogenesis is complex, resulting in a highly distorted and heterogeneous 
distribution of blood vessels in advanced cancers.23 This distorted distribution is 
dependent on angiogenic factors and related to the incorporation of existing host blood 
vessels into tumor and the creation of new tumor microvessels.24, 25 The distribution of 
these tumor vessels is highly heterogeneous.  Some areas may have high microvessel 
density especially at the periphery of the tumor; other areas may develop necrosis 
especially in the central region of the tumor.26, 27 In our pilot studies of imaging tumor 
vasculature using ultrasound-guided optical tomography, we have observed 
heterogeneous absorption distribution in advanced cancers.19, 21, 28 In this dissertaion, we 
have systematically investigated the capability of optical tomography to accurately image 
heterogeneous absorption distributions using Monte Carlo simulations and phantom 
experiments. A clinical example is given to show the complex vasculature distributions 
seen from an advanced cancer. To the best of our knowledge, this study is the first one to 
characterize and quantify the effects of target parameters, target locations and target 
optical properties on imaging heterogeneous absorption distributions of large targets in 
reflection geometry. Understanding and characterizing the features of advanced breast 
cancers imaged by optical tomography is a critical step toward translating this promising 
technique into clinical practice. It is also important to understand the initial angiogenesis 
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distributions and potential angiogenesis changes of advanced cancers when patients are 
undergone neoadjuvant chemotherapy.   
2.2  Methods 
2.2.1 Monte Carlo simulation  
The Time-Domain Monte Carlo (MC) method was used to generate the forward 
data with a target inside the turbid medium located at different depths. The details of the 
time-domain MC simulation developed by our group can be found in our previous 
works.29, 30 Briefly, the reflection geometry with multiple sources and detectors 
distributed on a probe of 10 cm diameter was used in the MC simulation (see Figure 2-1). 
At each source location, a delta pulse consisting of 30 millions of photons was lunched 
into the medium.  Initially, each photon was assigned a unity weight W, which is 
analogous to light intensity. Each photon went through many steps of absorption and 
scattering processes. After each step, a part of the weight W  was absorbed by the 
medium and the weight of the photon was decreased. The photon was scattered following 
the Henyey-Greenstein function. The Roulette technique was used to terminate the 
photon when the residual weight was less than a threshold value. For each photon, it was 
either absorbed in the medium, detected at the reflecting surface, or left from the 
transmitting surface. After the migration of one particular photon halted, a new photon 
was launched into the medium at the source location. In this simulation, the absorption 
boundary was used between the scattering medium and the outer surface. Each photon's 
energy and arrival time were recorded when the photon reached the outer surface 
(boundary).  The distribution or time profile of the recorded photons at each detector 
position for each delta pulse at a source position was stored and the resulting temporal 
13 
data were Fourier transformed to provide frequency domain amplitude and phase shift at 
140 MHz which was used in simulations.   
 
(a) (b)  
Figure 2-1 Probe geometry used for simulation and phantom experiments (a) without 
closer-to-center center sources and (b) with two closer-to-center sources. 
The MC program has been extended to include a larger semi-ellipsoidal 
inhomogeneous target embedded inside a turbid medium, which closely models large 
breast lesions when patients are imaged in a supine position using the conventional 
pulse-echo ultrasound and our hand-held combined probe. In addition, most of the large 
lesions are squashed into a semi-ellipsoidal shape against the chest-wall under the slight 
probe compression. Therefore, a semi-ellipsoidal target is a reasonable model for these 
lesions.  As shown in Figure 2-2 (a), the inhomogeneous target has two concentric 
semi-ellipsoids of different outer shell and inner core optical properties. The boundary 
conditions between target layers and medium could be easily controlled by mapping 
corresponding refractive indexes in an input file.  
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Figure 2-2 (a) Geometry of the photon propagation to the boundary of a concentric 
semi-ellipsoidal target. (b) W  inside the 3-D volume was summed in x direction (left), 
y direction (middle)  and z direction  (right), respectively and projected into the y-z 
plane, x-z plane and x-y plane, respectively. 
When a photon propagated to one of the boundaries between the target outer layer 
and the medium, the target outer layer and the core or the target core and the medium, the 
intersection point (point P in Figure 2-2 (a)) was computed and the shortened step size (s1) 
of this photon from B to P was calculated.  At the incident angle (∠NPB), Snell’s law 
was applied to calculate the reflection angle (∠NPC) and the refraction angle (∠MPD). 
After this the photon travels a distance s1, with the traveling direction being changed 
depending on different boundary conditions. If the photon experienced total internal 
reflection, the photon was propagated in the same medium in the reflection direction. If 
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the photon experienced partial internal reflection, one simplification was made by 
assuming that the photon would be either all reflected or all refracted. By comparing the 
reflection coefficient from Fresnel’s equations and a random number generated from a 
uniform distribution, the photon would be refracted only if the random number is larger 
than the reflection coefficient; otherwise, it would be reflected. Thus, the remaining step 
size (s2) of the photon was propagated in the corresponding medium determined above. 
As the photon propagated in the medium, part of the weight W was absorbed after each 
step. The absorbed W  inside the 3-D volume was summed in x direction, y direction, 
and z direction, respectively, and projected into the y-z plane, x-z plane, and x-y plane, 
respectively, as shown in Figure 2-2 (b).  
2.2.2 Imaging Reconstruction 
Born method was used to approximate the received photon density wave as a linear 
superposition of homogeneous incident and scattered fields originated from a source 
located at sr  and evaluated inside the medium at r.  
),(),(),( 0 rrUrrUrrU sSCss                                                 (1) 
Under the approximation that ),(),(0 rrUrrU sSCs  , SCU  could be derived as  
  rdrrUrrrGDrrU saddsSC 300 ),()()(/1),(                             (2) 
Where )( drrG   is the Green’s function, which relates the scattered field measured 
at the detector dr  to the field point r. )(ra  represents the absorption variation at the 
voxel r; and 0D  is the diffusion coefficient of the homogenous medium. 
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The dual-zone mesh scheme introduced by us earlier was used for inversion.31 
Briefly, the imaging volume was segmented into two regions consisting of the lesion (ROI) 
as identified by the co-registered ultrasound and the background region. We used a smaller 
fine mesh size for the lesion region and a larger coarse mesh size for the background region, 
so that the total voxels with unknown optical properties was significantly reduced and the 
inversion converged quickly in three to four iterations. The conjugate gradient method was 
used for the iterative optimization. Typically, in simulations and phantom experiments, the 
fine mesh region was chosen about 3-4 times larger than the true target area, and in clinical 
data, the fine mesh region was about 4.5 times larger than the lesion area estimated by 
ultrasound. Using this dual-zone mesh method, the scattered field can be related to the total 
absorption distribution as: 
T
BLNMBLMSC MMWWU ],[],[][ 1                                             (3) 
where LW  and BW  are the weight matrices for lesion region and background region, 
respectively; ]')'(,')'([ 3
1
3  
LL N
aaL rdrrdrM  and 
]')'(,')'([ 3
1
3  
BB N
aaB rdrrdrM   are the total absorption distribution of the 
lesion and the background regions, respectively. Here, the total absorption distribution was 
reconstructed rather than )'(ra . At the end of the iterative optimization, the total 
absorption distribution is divided by the different voxel sizes of the lesion and background 
to obtain )'(ra . This method significantly reduced the background artifacts because the 
voxel size in the background area was much larger than that in the lesion area.  
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For inhomogeneous concentric target, the inner core size of the reconstructed image 
was measured as 2 times of the mean value of xr  and yr  (as shown in Figure 3), where 
xr  was measured between the (maximum + minimum)/2 and minimum of the absorption 
curve along the x axis and yr  was measured similarly along the y axis. 
-5 -4 -3 -2 -1 0 1 2 3 4 5
0.02
0.04
0.06
0.08
0.1
0.12
0.14
0.16
inner radius
x
m
ua
rx
(b)
rx
ry
(a)
2
2
m
ua
m
ua
m
ua
 
Figure 2-3 Illustration of measuring reconstructed inner radius. 
2.2.3 Experiment 
Phantoms of different size with different optical properties were made using 
polyvinyl chloride-plastisol (PVCP) solution, which was a white opaque solution and 
became  translucent when it was heated to a high temperature.32 When the solution was 
gradually heated, the Indian ink and titanium dioxide (TiO2) powder were added to control 
the optical absorption and scattering coefficients of the phantom. The heated solution was 
poured into molds of a semi-ellipsoidal shape and solidified after cooling for several hours. 
For the special case of a larger target with different inner core optical properties, we made 
smaller targets first, and then proceeded the second time to make the larger target by 
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embedding the smaller ones inside. Thus the target outer shell and inner core had different 
optical properties.  An example of a concentric semi-ellipsoidal target phantom is given in 
Figure 2-4. The refractive index of the PVCP was reported in the literature 33, 34 and the 
range at closer to room temperatures was from 1.44 to 1.54.  MC simulations were 
performed to evaluate the effect of refractive index difference between the PVCP target 
and Intralipid solution on reconstructed target absorption.  The maximum difference in 
reconstructed absorption was about 0.02 cm-1 when the solid phantom of a =0.25 cm-1 
and liquid background and inner core of a =0.03 cm-1 were used. No change in target 
absorption distribution was observed. 
 
Figure 2-4 Example of a concentric semi-ellipsoidal target phantom.  (a) The front view 
of the phantom. (b) The bottom view of the phantom. 
Our frequency domain system consisted of 14 parallel detectors and 4 laser diodes 
of 740nm, 780nm, 808nm and 830nm. Each laser diode was sequentially switched to 9 
positions on the probe (see Figure 2-1 (a)). The center slot on the probe was used for 
ultrasound transducer and the sources and detectors were distributed on both sides. 
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Intralipid solution was used to emulate the background tissue. Measurements were made 
with the target inside the intralipid (target data) and intralipid alone as a reference. The 
target was supported by a 6 to 7 cm long optical fiber mounted on a piece of white clay 
located at the bottom of a 2 liter capacity tank filled with intralipid. The perturbation 
between the target data and the reference was used for imaging reconstruction. To 
compare reconstruction results with the closer to center source illumination when 
imaging a large semi-ellipsoidal inhomogeneous target, we also imaged the same target 
using the probe geometry shown in Figure 2-1 (b).  In this geometry, two sources from 
the left side of the probe were moved to the top and bottom sides of the ultrasound 
transducer location. The objective of the second set measurements was to estimate the 
effect of sources near the center on imaging reconstruction. 
Clinical experiments were performed with the system of the same design as that 
used for phantom experiments. The study protocol was approved by the local Institution 
Review Board (IRB) committee. All patients who participated in our study signed the 
informed consent. The patients’ data were taken at the lesion area and the contralateral 
breast of the same quadrant as the lesion. Contralateral data set was used to estimate 
background optical properties for weight matrix computation. The perturbation was 
computed between lesion data and contralateral data and used for imaging reconstruction. 
2.3 Results 
In this section, five sets of simulation and experiments have been reported in 
sections 2.3.1-2.3.5 and the clinical example has been given in section 2.3.6.  The first 
set simulation and experiments was performed using a homogeneous target. The result 
can serve as a baseline to compare with that obtained from an inhomogeneous target of a 
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semi-ellipsoidal shape of different outer shell and inner core optical properties. The 
second set of simulation and experiments was performed to investigate two important 
target parameters that affect the resolving capability of the optical tomography. The third 
set of simulation and experiments was designed to emulate the condition that a tumor 
with fixed outer-shell to inner-core contrast was located at different depths. The range of 
the target depths investigated was from 1.0 to 3.0 cm which was often encountered in the 
clinical studies when patients were scanned in a supine position. The fourth set of 
simulations and experiments was targeted to evaluate how the absorption of the inner 
core could affect the reconstructed contrast ratio of outer-shell to inner-core as well as the 
measured inner core size. In clinical studies, the center tumor core could have different 
absorption lower than the periphery due to rapid growth of the malignant cancer. The 
fifth set of the simulation and experiment was designed to investigate the effect of inner 
core diameter change on reconstructed contrast ratio of outer-shell to inner-core as well 
as measured inner core size. In clinical studies, we often encounter the necrotic core of 
dead tumor tissue of different size while the malignant tumor cells grow outward. At the 
end, we show a clinical example of a larger cancer imaged by our system. 
2.3.1 Homogeneous targets 
In this section, we show MC simulation and phantom results of a homogeneous 
target which can be used as a baseline to compare with that of inhomogeneous targets. 
In the MC simulation, a 5-cm-diameter of 2-cm-height semi-ellipsoidal target had 
optical properties of absorption coefficient a = 0.25 cm−1 and reduced scattering 
coefficient 's = 6.0 cm−1. The background properties were set to a = 0.03 cm−1 and 
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's = 6.0 cm−1.The target bottom was located at 2.5 cm depth from the surface. Figure 
2-5 (a) shows the reconstructed target absorption map.  The probe shown in Figure 2-1 
(b) was used for image reconstruction.  Tomography images are shown in seven slices at 
different depths from 0.5 cm to 3.5 cm with 0.5 cm increment in depth. The ROI is 
shown from the second slice and distributed in three layers in depth of 1.0, 1.5 and 2.0 
cm. The distribution at each layer is quite uniform. The reconstructed maximum a  was 
0.13 cm−1. A similar result was obtained from a phantom experiment as shown in Figure 
2-5 (b). The target had the same size and same optical properties as the simulation and 
reconstructed maximum absorption coefficient is 0.14 cm−1. The absorption map at each 
layer is quite uniform. 
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Figure 2-5 Reconstruction results of a concentric semi-ellipsoidal target with diameter of 5 
cm and height of 2 cm. (a) simulation and (b) phantom experiment. 
2.3.2 Effects of target parameters on imaging concentric inhomogeneous targets 
In this section, we evaluate two target parameters which are critical for imaging 
periphery enhancement absorption distribution. The thickness between the outer shell and 
the inner core t shown in Figure 2-2 (a) is an important parameter for resolving the target 
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inhomogeneity. In this set of simulation, a semi-ellipsoidal target was presented with 
outer diameter of 5.0 cm, inner core diameter of 2.5 cm, h of 2.0 cm and t of 0.5, 0.8 and 
1.0 cm, respectively. The target outer shell and inner core had same reduced scattering 
coefficient of 's = 6.0 cm−1 and different absorption coefficients of a = 0.25 cm−1 and 
a = 0.03 cm−1. The target bottom was located at 2.5 cm depth from the surface. The 
background optical properties were a = 0.03 cm−1 and 's = 6.0 cm−1. Error! 
Reference source not found. shows the reconstructed target absorption maps of different 
layer thickness of 0.5, 0.8 and 1.0 cm, respectively. The probe shown in Figure 2-1 (b) 
was used for image reconstruction. The reconstructed maximum a s were 0.13, 0.14 and 
0.13 cm−1, respectively. Using the method introduced in section 2.2, the measured inner 
diameter of the target region was 1.9, 1.4 and 0.3 cm.  
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Figure 2-6 Simulation results of a concentric semi-ellipsoidal target of outer shell diameter 
5 cm, inner core diameter 2.5 cm and height 2 cm of different layer thickness  (a) 0.5 cm, 
(b) 0.8 cm and (c) 1.0 cm. 
 
The corresponding phantom experiments were performed for the same size targets 
with layer thickness of 0.5 cm and 1.0 cm, respectively. Figure 2-7 shows the 
reconstruction results which had the maximum a = 0.15 cm−1 and a = 0.13 cm−1, 
respectively. When the thickness t is less than 1.0 cm, the inner core is visible. However, 
when t is larger than 1cm, the inner core cannot be resolved, even the core diameter is 
relatively large. This is caused by the increased scattering events when photons pass the 
outer shell of more than 1.0 cm thick and the information loss between the two groups of 
photons passing outer shell only and passing the outer shell and the inner core. 
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Figure 2-7 Phantom experimental results of a concentric semi-ellipsoidal target of outer 
shell diameter 5 cm, inner core diameter 2.5 cm, and height 2 cm of different layer 
thickness (a) -(b) 0.5 cm and (c)-(d) 1.0 cm. (a) and (c) are ultrasound images and (b) and 
(d) are corresponding absorption maps. 
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Figure 2-8 Simulation results of concentric semi-ellipsoidal targets with fixed layer 
thickness t= 0.5 cm and different target size. (a) outer shell diameter of 2.5 cm and inner 
core diameter of 1.5 cm; (b) outer shell diameter of 3 cm and inner core  diameter of 2 cm; 
(c) outer shell diameter of 3.5 cm and inner core diameter of 2.5 cm; (d) outer shell 
diameter of 5 cm and inner core diameter of 4.0 cm. 
Another important parameter is the target size. A series of MC simulations was 
performed by fixing t to 0.5 cm and varying the target size from 2.5 cm to 5.0 cm. The 
reconstruction results are shown in Figure 2-8. Figure 2-8 (a)-(d) are the absorption maps 
of the 2.5, 3.0, 3.5 and 5.0 cm diameter target with 1.5, 2.0, 2.5 and 4.0 cm inner core 
size, respectively.  The probe shown in Figure 2-1 (b) was used for the imaging 
reconstruction.  The target bottom was located at 2.5 cm. The maximum absorption 
coefficients were 0.14, 0.14, 0.15 and 0.14 cm−1, respectively. The reconstructed inner 
diameters were 0.0, 1.2, 1.8 and 2.6 cm, respectively. As one can see, the target size has 
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to be larger than 3.0 cm for resolving target outer shell and inner core. The simulation 
results were validated by experiments. An example of 2.5 cm diameter target of 1.5 cm 
inner core size is shown in Figure 2-9. In this example, the target inner core cannot be 
resolved. 
Based on the simulations and experiments, we used t= 0.5 cm layer thickness and 5.0 
cm target diameter for all simulations and experiments reported in the following sections to 
investigate the effect of other parameters on imaging target inhomogeneity. 
(a) (b)
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Figure 2-9 Phantom result of a small concentric semi-ellipsoidal target with outer shell 
diameter of 2.5 cm, inner core diameter of 1.5 cm, height of 1.5 cm and layer thickness of 
0.5 cm. (a) US image, (b) reconstructed absorption map 
2.3.3 An inhomogeneous target located in different depths 
This set of experiments was designed to investigate the effect of target depth on the 
reconstructed contrast of a target having a fixed outer shell to inner core absorption ratio, 
and the measured inner core diameter. The target depths evaluated were in the range of 
1.0 to 3.0 cm and correspond to those often encountered in the clinical studies. 
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A semi-ellipsoidal target presented in this set of simulation had outer diameter of 
5.0 cm, inner core diameter of 2.5 cm, h of 2.0 cm and t of 0.5 cm. The target outer shell 
and inner core had same reduced scattering coefficient of 's = 6.0 cm−1 and different 
absorption coefficients of a = 0.25 cm−1 and a = 0.06 cm−1, respectively. The 
background optical properties were set to a = 0.03 cm−1 and 's = 6.0 cm−1. Figure 
2-10 shows the reconstructed absorption maps of the target with the bottom of the target 
located at 2.3, 2.5, 2.8 and 3.0 cm from the probe surface, respectively. The probe with 
closer to center sources shown in Figure 2-1 (b) was used to obtain the measurements, 
The reconstructed maximum a s were 0.12, 0.13, 0.12 and 0.11 cm−1, respectively, 
which were quite close at all depths studied. The measured inner diameters were 1.9, 1.9, 
1.5 and 0.0 cm, respectively. The periphery of the target showed higher absorption than 
the inner core for the first three sets of experiments and the periphery enhancement was 
disappeared when the target was located deeper (Figure 2-10 (d)). The ring shape was 
ideally seen in the reconstructed absorption map at different target layers in Figure 2-10 
(a)-(c). In our clinical studies, the center slot dimension was adapted to the commercial 
ultrasound transducer used and the space for center sources was limited. To evaluate how 
much closer-to-center sources can affect the reconstructed target inhomogeneity, we used 
the probe without center sources to perform the simulation again. Figure 2-11 shows the 
reconstruction results of the same target located at the corresponding depths as that of 
Figure 2-10. The reconstructed maximum a s were a = 0.14, 0.14, 0.14 and 0.11 cm−1, 
respectively. We can clearly see that the absorption at the first target layer was higher at 
the two sides where the sources were distributed (Figure 2-11 (a)-(c)). However, the 
higher absorption at both sides of the target was clearly visible. We can see that the 
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maximum reconstructed values were quite close at the depths studied, however, the 
measured inner diameter was getting smaller and smaller when the target was deeper. 
When the target bottom reached 3.0 cm, the outer and inner layers merged together. 
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Figure 2-10 Simulation results of a concentric semi-ellipsoidal target of outer shell 
diameter  5 cm, inner core diameter 2.5 cm, height 2 cm and layer thickness  0.5 cm 
located at different depths. Distance between the bottom of the target and the probe surface 
was (a) 2.3 cm (b) 2.5 cm (c) 2.8 cm, and (d) 3.0 cm.  Probe of Figure 2-1 (b) was used for 
image reconstruction. 
A phantom experiment was performed under a similar condition as the simulation. 
Intralipid solution of calibrated a = 0.03 cm−1 and 's =7.2 cm−1 at 780 nm wavelength 
was used as the background. The target shown in Figure 4 had outer shell diameter of 5.0 
cm, inner core diameter of 2.5 cm, height h of 2.0 cm and t of 0.5 cm. Shell had the a = 
0.25 cm−1 and 's = 7.1 cm−1 and the core had a = 0.06 cm−1 and 's = 5.2 cm−1. Figure 
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2-12 shows the reconstruction results of the target located at different depths using the 
probe shown in Figure 2-1 (b). Figure 2-12 (a)-(d) show the reconstructed absorption maps 
when the target was located at the corresponding depths as Figure 2-10. The reconstructed 
maximum a s were 0.15, 0.14, 0.13 and 0.15 cm−1, respectively. The reconstructed inner 
core diameters were 2.0, 2.0, 1.4 and 0.0 cm, respectively. When the target bottom was 
located at 3.0 cm, the outer and inner regions were merged together and target appeared as 
a homogeneous one. 
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Figure 2-11 Simulation results of a concentric semi-ellipsoidal target of outer shell 
diameter  5 cm, inner core diameter  2.5 cm, height  2 cm and layer thickness  0.5 cm 
located at different depths. Distance between the bottom of the target and the probe surface 
was (a) 2.3 cm (b) 2.5 cm (c) 2.8 cm, and (d) 3.0 cm. Probe of Figure 2-1 (a) was used for 
image reconstruction. 
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Figure 2-12 Phantom results of a concentric semi-ellipsoidal target with outer shell 
diameter of 5 cm, inner core diameter of 2.5 cm, height of 2 cm and layer thickness of 0.5 
cm located at different depths. Distance between the bottom of the target and the probe 
surface was (a) 2.3 cm (b) 2.5 cm (c) 2.8 cm, and (d) 3.0 cm.  Probe of Figure 2-1 (b) was 
used for image reconstruction. 
To verify the simulation results without center sources, we used the probe shown in 
Figure 2-1 (a) to obtain data of the same target at the same depth as used for Figure 2-12. 
The result is shown in Figure 2-13. The reconstructed maximum a s were 0.14, 0.14, 
0.13 and 0.14 cm−1, respectively, which were very close to that obtained from Figure 2-12. 
The ring pattern is clearly visible, however, the shape is not as good as the one obtained 
with the center sources shown in Figure 2-12. 
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Figure 2-13 Phantom results of a semi-ellipsoidal target with outer shell diameter of 5 cm, 
inner diameter of 2.5 cm, height of 2 cm and layer thickness of 0.5 cm located at different 
depths. Distance between the bottom of the target and the probe surface was (a) 2.3 cm, (b) 
2.5 cm, (c) 2.8 cm, and (d) 3.0 cm. Probe of Figure 2-1 (a) was used for image 
reconstruction. 
Figure 2-14 provides more quantitative comparison of both simulation and phantom 
experiments.  As given before the true a s of the outer shell and inner core for both 
simulation and experiment were a =0.25 cm−1 and a =0.06 cm−1, so the true ratio was 
4.17. The reconstructed ratio was defined as the maximum value over the minimum value 
inside the target region. The reconstructed ratios for simulation shown in Figure 2-10 
(a)-(d) were 2.12, 2.08, 1.66 and 1, respectively. The corresponding ratios for experiment 
shown in Figure 2-12 were 1.83, 1.53, 1.32 and 1.0, respectively. The true inner 
diameters for both simulation and phantom experiments were 2.5 cm. The measured inner 
diameters were 1.9, 1.9 and 1.5 cm, respectively, in Figure 2-10 (a)-(c); and the 
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corresponding measured values were 2.0, 2.0 and 1.4 cm, respectively, in Figure 2-12 
(a)-(c). As expected, when the target depth increased, the reconstructed ratio as well as 
the measured inner diameter reduced because the received photons that passed through 
the outer shell only and the outer shell and inner core went through more scattering 
events. As a result, the location information that these two groups of photons carried was 
lost in the scattering process. 
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Figure 2-14 Plot of contrast ratio (left y axis) and reconstructed inner diameter (right y axis) 
vs. target depths. 
2.3.4 An inhomogeneous target with different inner core absorption  
This set of simulation and phantom experiment demonstrates how the absorption of 
the inner core affects the reconstructed contrast ratio of outer shell to inner core as well as 
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the measured inner core size. Both MC simulation and phantom experiments were 
performed under the similar conditions. In clinical studies, the center tumor core could 
have different absorption lower than the periphery due to rapid growth of the malignant 
cancer. 
In this set of simulation, the semi-ellipsoidal target had the outer diameter of 5 cm, 
the inner core diameter of 2.5 cm, h of 2 cm and t of 0.5 cm. The absorption coefficient 
of the outer layer was fixed to a = 0.25 cm−1 and the inner core a  was changed to 
0.03, 0.06, 0.08 and 0.15 cm−1, respectively. The reduced scattering coefficient of both 
shell and core is the same as 's = 6.0 cm−1. The target bottom was located at 2.5 cm 
from the probe surface. The background properties were a = 0.03 cm−1 and 's = 6.0 
cm−1. Figure 2-15 shows the reconstruction results of the target with fixed outer layer 
absorption and different inner core absorption using the probe shown in Figure 2-1 (b). 
As shown in Figure 2-15, the reconstructed maximum a s were 0.14, 0.13, 0.13 and 
0.13 cm−1, respectively. The reconstructed inner diameter of the center region was 2.0, 
1.9, 1.5 and 1.5 cm as shown in Figure 2-15 (a)-(d). As expected, the inner core 
absorption does not affect the reconstructed maximum value because the outer shell 
absorption was fixed. However, as the inner core absorption increases, the contrast ratio 
of the shell and the core decreases and the measured inner diameter reduces. If we use the 
probe without center sources as shown in Figure 2-1 (a), the maximum a s were 0.14, 
0.14, 0.13 and 0.13 cm−1, respectively. Similar as the results shown in section 2.3.3, the 
probe shown in Figure 2-1 (b) with the center sources reconstructs the target shape better 
than that of probe shown in Figure 2-1 (a); while the reconstructed maximum a s were 
very similar by using both probes. 
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Figure 2-15 Simulation results of a concentric semi-ellipsoidal target of outer shell 
diameter 5 cm, inner core diameter 2.5 cm, height 2cm and layer thickness 0.5 cm of 
different inner core absorption coefficients. Probe shown in Figure 2-1 (b) was used for 
image reconstruction. Inner core absorption coefficient was (a) 0.03 cm−1, (b) 0.06 cm−1, (c) 
0.08 cm−1, and (d) 0.15 cm−1, respectively. 
The phantom target was made of a fixed outer shell absorption a = 0.25 cm−1 and 
reduced scattering coefficient 's = 7.1 cm−1, but of different inner core a = 0.03, 0.06, 
0.08 and 0.15 cm−1, respectively, and the reduced scattering coefficients of 's = 7.2, 5.2, 
7.9, 9.0 cm−1, respectively. Similar to the simulation, the outer target diameter was 5 cm, 
the inner core 2.5 cm, h= 2 cm and t= 0.5cm.  Figure 2-16 shows the reconstruction 
results of the target of different inner core absorption coefficients. The intralipid solution 
used as the background had a = 0.03 cm−1 and 's =7.2 cm−1 at 780 nm wavelength. 
The probe shown in Figure 2-1 (b) with center sources was used. In Figure 2-16 (a)-(d), 
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the reconstructed maximum a s were 0.16, 0.17, 0.17 and 0.17 cm−1, respectively. 
Similar to the simulation, the maximum values do not change much with the different 
inner core absorption coefficients. However, the measured inner core diameters were 2.2, 
1.9, 1.6 and 1.3 cm accordingly. The measured inner core diameter reduces as the target 
contrast of outer shell and inner core decreases. The reconstructed absorption map using 
probe given in Figure 2-16 (a) has maximum a s 0.15, 0.16, 0.16, and 0.17 cm−1, 
respectively, which were very close to the corresponding values given in Figure 2-16. 
However, the ring-shape of the target was not as good as shown in Figure 2-16. 
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Figure 2-16 Phantom results of a concentric semi-ellipsoidal target of outer shell diameter 
5 cm, inner diameter 2.5 cm, height 2cm and layer thickness 0.5 cm of different inner core 
absorption imaged. Probe shown in Figure 2-1 (b) was used for image reconstruction.  
Inner core absorption coefficient was (a) 0.03 cm−1, (b) 0.06 cm−1, (c) 0.08 cm−1, and (d) 
0.15 cm−1, respectively. 
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Figure 2-17 compares the simulation and phantom experiments for targets with 
different outer shell and inner core contrast. The dash lines represent simulation results 
and the solid lines are that of phantom experiments. Three groups of data are: true 
contrast ratio, reconstructed ratio of outer shell over inner core absorption coefficients, 
and measured inner core diameters. As one can see, the experimental results agree well 
with simulation data.   
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Figure 2-17 Plot of contrast ratio (left y axis) and reconstructed inner diameter (right y axis) 
vs. different inner core absorption. 
For both simulation and phantom experiments, the true ratios of outer shell to inner 
core absorption were 8.33, 4.17, 3.13 and 1.67, respectively. The reconstructed ratio was 
the measured maximum absorption over the minimum inside the target region. The 
reconstructed ratios of simulation were 2.25, 2.08, 1.75 and 1.59 for inner core a =0.03, 
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0.06, 0.08 and 0.15 cm−1, respectively. These ratios were 2.46, 2.10, 1.78 and 1.77, 
respectively, as measured in experiments. The measured inner diameters were 2.0, 1.9, 
1.5 and 1.5 cm in simulation, respectively, while the measured diameters were 2.2, 1.9, 
1.6 and 1.3 cm, respectively in experiments. It is interesting to note that the true ratio of 
outer shell to inner core absorption reduces rapidly with the increase of inner core 
absorption; however, the reconstructed ratio in both simulation and experiments reduces 
gradually. Because of the intense scattering of photons in the turbid medium, the 
reconstructed ratios can only reach about a factor of two. The measured inner diameter 
also reduces with the increase of inner core absorption. 
2.3.5 An inhomogeneous target with different inner diameter  
This set of experiments was designed to investigate the effect of inner core 
diameter change on reconstructed contrast ratio of outer shell and inner core optical 
absorptions as well as measured inner core size. 
The target had fixed outer shell and inner core optical properties of a = 0.25 cm−1, 
's = 6.0 cm−1 and a = 0.03 cm−1, 's = 6.0 cm−1, respectively. The outer diameter and 
layer thickness t were fixed to 5 cm and 0.5 cm, respectively and the core diameters were 
changed from 1.0 to 1.5, 2 and 2.5 cm, respectively. The background properties were 
a = 0.03 cm−1 and 's = 6.0 cm−1. The simulations were processed with center sources 
as shown in Figure 2-1 (b). Figure 2-18 shows the reconstructed image. Figure 2-18 (a) is 
the image of target with 1.0 cm inner core diameter. The maximum value of a  was 
0.12 cm−1 and the measured inner core diameter was 1.5 cm. Figure 2-18 (b)-(d) are the 
reconstructed images with 1.5, 2.0, and 2.5 cm inner core diameters, respectively. The 
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corresponding measured maximum absorption were 0.13, 0.13 and 0.13 cm−1; while the 
measured inner core diameters were 1.52, 1.9, and 1.9 cm, respectively. As expected, the 
maximum reconstructed values are similar because of the fixed absorption of the outer 
shell, and the reconstructed inner core diameter increases with the increase of the inner 
core diameter size. 
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Figure 2-18 Simulation results of a concentric semi-ellipsoidal target of outer shell 
diameter 5 cm, inner core diameter 2.5 cm, height 2 cm and layer thickness  0.5 cm of  
different inner core diameters.  Probe shown in Figure 2-1 (b) was used for image 
reconstruction. Inner core diameter was (a) 1.0 cm, (b) 1.5 cm, (c) 2.0 cm, and (d) 2.5 cm. 
To validate the simulation results, phantom experiments with the similar condition 
were performed. Because of the difficulty of making different phantoms with exactly the 
same inner core size as the simulation, we used the same phantom by gradually enlarging 
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the inner core size to perform the experiments. To do so, the optical properties of the 
outer shell and inner core did not change and the only variable was the inner core size. 
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Figure 2-19 Phantom results of a concentric semi-ellipsoidal target of outer shell diameter 
of 5 cm, inner core diameter of 2.5 cm, height  of 2cm and layer thickness 0.5 cm of  
different inner core diameters.   Probe shown in Figure 2-1 (b) was used for image 
reconstruction.  Inner diameter was (a) 1.0 cm, (b) 1.5 cm, (c) 2.0cm, and (d) 2.5 cm. 
The optical properties of the outer shell were a = 0.25 cm−1, 's = 7.1 cm−1, the 
diameter was 5 cm and the t was 0.5 cm. The inner core was filled with intralipid solution 
of calibrated a = 0.03 cm−1 and 's = 7.2 cm−1. Experiments of four different inner core 
diameters of 1.0, 1.5, 2 and 2.5 cm were performed with results shown in Figure 2-19, 
respectively. The probe of Figure 2-1 (b) was used for this set of experiments. The 
reconstructed maximum a s in Figure 2-19 (a)-(d) were 0.14, 0.15, 0.14 and 0.15 cm−1, 
respectively; while the measured inner core diameters were 1.3, 1.6, 1.9 and 2.2 cm, 
respectively. The phantom experiments closely follow the simulation, and further 
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demonstrate that maximum values do not change much for the fixed outer layer, however, 
the measured inner diameter increases with the increase of the true hollow inner core 
size. 
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Figure 2-20 Plot of contrast ratio (left y axis) and reconstructed inner diameter (right y axis) 
vs. the inner core diameter. 
Figure 2-20 shows the simulation and phantom experimental results for targets with 
different inner diameters. The dash lines represent simulation results and the solid lines 
are that of phantom experiments. The three groups of data are: true absorption ratio, 
reconstructed ratio of outer shell over inner core absorptions, and measured inner core 
diameter for target of different inner core size. The true contrast ratio of outer shell over 
inner core absorption was 7.6. The reconstructed ratios from simulations were 1.52, 1.60, 
1.84 and 2.08, respectively; these values were 1.28, 1.34, 1.68 and 1.84 for experiments. 
The measured diameters were 1.5, 1.5, 1.9 and 1.9 cm in simulation, and were 1.3, 1.6, 
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1.9 and 2.2 cm in experiments, respectively. Comparing the reconstructed ratios with the 
true ratio, we see that the reconstructed ratios can only reach a factor of two and increase 
with the increase of the inner core diameter. Correspondingly, the measured inner core 
diameter increases with the increase of the true diameter size. 
Slice 1
-4 -2 0 2 4
-4
-2
0
2
4 0
0.1
0.2
Slice 2
-4 -2 0 2 4
-4
-2
0
2
4 0
0.1
0.2
Slice 3
-4 -2 0 2 4
-4
-2
0
2
4 0
0.1
0.2
Slice 4
-4 -2 0 2 4
-4
-2
0
2
4 0
0.1
0.2
Slice 5
-4 -2 0 2 4
-4
-2
0
2
4 0
0.1
0.2
Slice 6
-4 -2 0 2 4
-4
-2
0
2
4 0
0.1
0.2
Slice 7
-4 -2 0 2 4
-4
-2
0
2
4 0
0.1
0.2
Slice 1
-4 -2 0 2 4
-4
-2
0
2
4 0
0.1
0.2
Slice 2
-4 -2 0 2 4
-4
-2
0
2
4 0
0.1
0.2
Slice 3
-4 -2 0 2 4
-4
-2
0
2
4 0
0.1
0.2
Slice 4
-4 -2 0 2 4
-4
-2
0
2
4 0
0.1
0.2
Slice 5
-4 -2 0 2 4
-4
-2
0
2
4 0
0.1
0.2
Slice 6
-4 -2 0 2 4
-4
-2
0
2
4 0
0.1
0.2
Slice 7
-4 -2 0 2 4
-4
-2
0
2
4 0
0.1
0.2
Slice 1
-4 -2 0 2 4
-4
-2
0
2
4
0
50
100
Slice 2
-4 -2 0 2 4
-4
-2
0
2
4
0
50
100
Slice 3
-4 -2 0 2 4
-4
-2
0
2
4
0
50
100
Slice 4
-4 -2 0 2 4
-4
-2
0
2
4
0
50
100 Slice 5
-4 -2 0 2 4
-4
-2
0
2
4
0
50
100 Slice 6
-4 -2 0 2 4
-4
-2
0
2
4
0
50
100
Slice 7
-4 -2 0 2 4
-4
-2
0
2
4
0
50
100
(a) (b)
(c) (d)
 
Figure 2-21 Clinical example of an advanced cancer. (a) Co-registered US showed a 
suspicious mass of a semi-spherical shape with top and bottom located at 0.5 cm and 2.5 
cm from the skin surface. Core-biopsy revealed a high grade ductal carcinoma. (b) Optical 
absorption map reconstructed at 780 nm; (c) Absorption map reconstructed at 830 nm, and 
(d) Computed total hemoglobin concentration map. 
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2.3.6 Clinical example 
A clinical example of an advanced cancer of approximately 4cm size is given in 
Figure 2-21. The co-registered ultrasound showed a highly suspicious mass located at the 
left breast of 3 o’clock position of an 86-year old woman. The lesion top and bottom 
were approximately located at 0.5 cm and 2.5 cm depth from the skin surface. 
Ultrasound-guided biopsy reveled that the mass was a high grade (nuclear grade II, 
histology grade III) invasive ductal carcinoma. Further evaluation of H&E stained 
histology slides showed extensive tumor necrosis which occupied about 40% of the core 
biopsy samples. Optical absorption maps obtained at 780nm (b) and 830nm (c) showed 
higher periphery contrast than the inner core area. The computed total hemoglobin 
concentration showed similar periphery enhancement of maximum and average 
concentrations of 86  Mol/Liter and 55  Mol/Liter, respectively. This type of 
periphery enhancement is often seen in advanced cancers. 
2.4  Discussion and summary 
Angiogenesis patterns of advanced breast cancers are complex, and there is no 
unique feature that can uniquely characterize these tumors. From our on-going clinical 
studies, we have seen two typical types of absorption or vasculature distribution patterns of 
advanced cancers: periphery enhancements or posterior shadowing.19 More interestingly, 
the periphery enhancements are often seen in high grade tumors19 which have been 
reported in MRI literature as well.26, 27 Posterior shadowing is caused by significant light 
absorption of a highly vascularized tumor, which causes a dramatic reduction of the 
reflected light received from the deeper portion of the tumor. As a result, the reconstructed 
absorption maps of these large tumors have shown much higher light absorption at the top 
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portion than that of the deeper portion.30 This shadowing effect is similar to the posterior 
shadowing seen in pulse-echo ultrasound when imaging larger tumors. The presence of 
significant posterior shadowing of a lesion in ultrasound images suggests malignance.35   
To characterize and quantify periphery enhancement features of optical tomography 
when imaging these larger cancers, we performed five sets of simulations and phantom 
experiments in the reported study. As shown in the studies, two target parameters affect 
the resolving capability of optical tomography: the layer thickness between the outer shell 
and the inner core and the target size.  In order to resolve the inner core, the layer 
thickness has to be less than 1 cm and the target size has to be larger than 3 cm. 
Concentric inhomogeneous targets of thicker layers and smaller diameters may not show 
periphery enhancement features in images. This result may explain why we have 
observed the periphery enhancement in advanced cancers of high grade tumors which 
grow rapidly outward with extensive dead necrotic core. In addition, the periphery 
enhancement occurs at target depths less than 3 cm. Deep concentric inhomogeneous 
targets may not show this feature in images due to intense light scattering in tissue. 
Therefore, quantifying target parameters and target depth is critically important when 
using periphery enhancement feature to assist ultrasound diagnosis of advance cancers. 
Certainly, their parameters may vary to some extend based on individually patient’s bulk 
absorption and scattering coefficients. The inner core optical absorption and size also 
affect imaging periphery enhancement features to some extend. The reported 
investigation on near center source illumination also provides an important guideline for 
the probe design. As shown from the studies, two near center sources at the top and 
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bottom sides of the ultrasound probe are needed for improving visualization of the target 
heterogeneity. This is feasible in the probe design using ultrasound guidance. 
Because of the large target size studied, multiple fine-mesh target layers in depth 
were used in image reconstruction. As a result, more voxels with unknown optical 
properties were reconstructed and the lesion quantification was about 50-60% which was 
lower than that of 70-85% obtained from smaller targets.29, 36 The measured contrast of 
the higher target absorption periphery over the lower absorption core was about a factor 
of 2 at the best imaging condition. This is due to the intense scattering events of diffused 
photons which cause the information loss between the two groups of photons passing 
outer shell only and passing the outer shell and the inner core. Interestingly, several 
groups have reported the factor of 2 contrast between malignant lesions and background 
tissues using different instrumentation and different measurement methods.10, 37 
In summary, we have shown that large inhomogeneous concentric semi-ellipsoidal 
targets with outer shell thickness less than 1 cm can be resolved at the typical depth range 
for breast imaging when reflection geometry is used. For large breast lesions of more 
than 3 cm in size, the periphery enhancement feature can be used to assist ultrasound 
diagnosis of benign versus malignance. 
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3 Clustered targets imaged by optical tomography 
guided by ultrasound 
3.1  Introduction 
DOT in the NIR spectrum provides a unique approach for functional diagnostic 
breast imaging and for monitoring chemotherapy response of advanced breast cancers.1-19 
However, the primary limitation of DOT is related to the intense light scattering in tissue 
which dominates NIR light propagation. As a result, the resolution of the DOT is low and 
the localization of lesions is poorer. In addition, the accurate quantification of lesion 
optical properties is difficult with DOT. Optical tomography guided by co-registered US, 
MRI, and x-ray has demonstrated a great clinical potential to overcome lesion location 
uncertainty and to improve light quantification accuracy.1, 5, 17, 20-24 In the co-registration 
approach, a region of interest (ROI) containing a suspicious lesion seen by US or other 
imaging modalities is used to guide the DOT image reconstruction. 
Our group has developed a unique approach of using co-registered US to guide the 
lesion localization and using DOT to map the lesion vasculature. This approach has 
successfully overcome the location uncertainty of pure DOT approach.18, 25, 26 For a single 
target, this approach can achieve 61-77% accuracy for high contrast 1 cm targets and 
79-113% for low contrast targets of the same size. The accuracy for larger targets is 
lower in general in the range of 33-48% and 81-101% for high and low contrast targets, 
respectively.27 A recent paper by Ghadyani et al. has reported 85% accuracy in 
simulations when a contrast details analysis is used to recover the optical properties of 
anomalies guided by the MR imaging.1, 5 Studies using x-ray as the prior information 
demonstrated 90% accuracy for small volume problems.22 There are other groups using 
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spatial prior information to guide DOT imaging, for example, Tian et al has presented a 
best recovering rate of 64% of dual targets with a new depth compensation algorithm in 
simulations.28, 29 
In the dual-zone mesh method we introduced earlier,30 the ROI was segmented into 
a finer mesh and the background region was segmented into a coarse mesh. The inversion 
was well conditioned by this dual-zone mesh scheme and converged quickly in three to 
four iterations. In the presence of multiple targets, multiple ROIs are needed to guide the 
DOT image reconstruction. In this paper, we extend the dual-zone mesh method to 
include multiple ROIs when multiple targets are present. We evaluate the performance of 
the multi-zone method using simulations and phantom experiments. Clinical examples 
are given to demonstrate the improvement of lesion characterization using this method.  
Although the capability of DOT alone in distinguishing multiple targets was evaluated by 
several research groups,16, 28, 31-33 the use of a prior knowledge of multiple lesions seen by 
US has not been investigated. This study will systemically evaluate the performance of 
the multi-zone algorithm and the improvement of this method in target quantification. 
3.2  Methods 
3.2.1 Reconstruction algorithms  
In the single ROI dual-zone-mesh based image reconstruction, the imaging volume 
was segmented into two regions consisting of the lesion (L) as identified by the 
co-registered ultrasound and the background (B) region. A finer imaging voxel is used for 
lesion region and a coarse imaging voxel is used for background region. A modified Born 
approximation is used to relate the scattered field ),,( disisd rrU  measured at the source 
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(s) and detector (d) pair i to absorption variations )'(ra  in each volume element of 
the two regions within the sample, where sir  and dir  are the source and detector 
positions, respectively. The matrix form of the image reconstruction is given as: 
   
T
BLNMBLMSC MMWWU ],[],[][ 1                        (1) 
where LW  and BW  are weight matrices for the target and background regions, 
respectively. Instead of reconstructing a , the integral absorption distribution M is 
reconstructed, which is the product of a  times voxel size in discrete form. The M 
matrix is segmented into two regions, L and B, where 
]')'(,')'([ 3
1
3  
LL N
aaL rdrrdrM   and ]')'(,')'([ 31 3   BB N aaB rdrrdrM  . 
After reconstructing M, we divide it by different voxel sizes of L and B to obtain a  
distribution. By using a finer mesh for L region and a coarser mesh for B region, we 
reduce the total number of voxels with unknown optical properties for improving 
inversion. In addition, the M is reconstructed rather than absorption distribution per se, 
which further conditions the inversion because the M in the lesion region with a higher 
absorption and a finer voxel grid is in the same scale as the M in the background region 
with a lower absorption and a courser grid. The weight matrices are calculated based on 
the background absorption coefficient a  and reduced scattering coefficient s'  
measured from the homogeneous intralipid solution in phantom studies and normal 
contralateral tissue in clinical studies. 
For more than one target, the performance of the single ROI based dual-mesh 
scheme is degraded because of the increased number of fine-mesh grids with unknown 
optical properties. As a result, the lesion quantification is poor. We have extended the 
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dual-zone mesh method to multiple zones based on the ROIs identified by ultrasound.  
If N targets present, we divide the region of interest (ROI) into N zones either in a single 
layer or multiple layers in depth denoted as ROI#1, ROI#2, … ROI#N, respectively.  
The equation (1) is modified as: 
T
BLNLLNMBNLLLMSC MMMMWWWWU ],....[],....,[][ ,,2,1,211    ,                 (2) 
where the 1LW , 2LW , …… and LNW  are the weight matrices for the targets, and BW  is 
the weight matrix for the background tissue. 1LM , 2LM .. …. and LNM  are the integral 
absorption distributions of the corresponding targets and BM  is that of the background 
region. The absorption distributions can be computed by dividing the corresponding 
voxel size in ROIs and the background regions. 
For experiments and clinical cases, we have used 0.25 x 0.25 x 0.5 cm3 for the finer 
grid inside the lesion and 1.0 x 1.0 x 1.0 cm3 in the background region. The total imaging 
volume is 9.0 x 9.0 x 4.0 cm3. The choice of the imaging grids is based on the 
considerations of the system signal to noise ratio and the total number of voxels with 
unknown optical properties. The total number of finer and coarser voxels depends on 
target size. For typical 1-cm dual targets, the total numbers of finer and coarser voxels are 
242 and 324 (total 566), respectively, when a dual ROI is used. These numbers are 441 
and 321 (total 762), respectively, when a single ROI is used. For simulations, we have 
used 0.15 x 0.15 x 0.5 cm3 for the finer grid and the same coarse grid as the experiments. 
The corresponding numbers are 402 and 324 (total 726) for a dual ROI scheme, and 1258 
and 324 (total 1582) for a single ROI scheme. 
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3.2.2 Simulations and phantom experiments  
In the simulation, a commercial finite-element (FEM) package COMSOL was 
employed to solve the forward diffusion equation in the frequency domain.34, 35 140 MHz 
modulation frequency was used in all the simulations. A cylinder of 20 cm diameter and 
10 cm height was used to model the semi-infinite medium, and 9 sources and 14 detectors 
were distributed on the surface in reflection geometry as shown in Figure 3-1. Two 
spherical absorbers of same or different absorption coefficients were embedded in the 
scattering medium. The optical properties of the medium were a = 0.03 cm−1 and 's = 
6.0 cm−1, which were typical values of fatty breast tissue.23, 35, 36 Targets’ a  and 's  
were changed based on the different types of tumor targets simulated, for example, the 
high contrast target of a = 0.25 cm−1 and 's = 6.0 cm−1 was used to simulate 
malignant tumors and the low contrast target of a = 0.07 cm−1 and 's = 6.0 cm−1 was 
used to simulate benign lesions. 
source
detector
 
Figure 3-1 Probe geometry used for simulations and phantom experiments. The probe is of 
1 cm thickness and the center slot is used for US transducer. 
53 
In the phantom experiments, the frequency domain system36 consisted of 14 
parallel detectors and 4 laser diodes of wavelength 740nm, 780nm, 808nm and 830nm, 
respectively. Each laser diode was sequentially switched to 9 positions on the probe. The 
central slot on the probe shown in Figure 3-1 was used to fit the ultrasound transducer, 
and the sources and detectors were distributed on both sides. Polyester resin spheres of 
calibrated values a = 0.23 cm-1 and 's = 5.45 cm-1, and a = 0.07 cm-1 and 's = 5.50 
cm-1 were used to emulate high contrast tumors and low contrast benign lesions.  
Intralipid solution of a = 0.03 cm−1 and 's =7.2 cm−1 was used to emulate the 
background tissue. Measurements were made with the target inside the intralipid (target 
data) and intralipid alone as a reference. The perturbation between the target data and the 
reference was used for imaging reconstruction. 
Clinical experiments were performed at University of Connecticut Health Center.  
The study protocol was approved by the local Institution Review Board (IRB) committee.  
All patients who participated in our study signed the informed consent. The data were 
taken at the patients’ lesion area and the contralateral breast of the same quadrant of the 
lesion.  Contralateral data set was used to estimate background optical properties for 
weight matrix computation. The perturbation computed between the lesion data and the 
contralateral data was used for imaging reconstruction 
3.3  Results 
3.3.1 Two targets with different contrast  
In some clinical cases, patients may have multiple lesions with malignant or benign 
characteristics. To evaluate the performance of our multi-zone ROIs approach, we have 
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performed simulations and experiments by using two targets of same size but different 
contrast. 
A series of FEM simulations were conducted for two types of targets, one high and one 
low contrast absorbers. Both targets had the same diameter of 1.0 cm and located at same 
depth with center-to-center separations of 1.5, 2.0, 2.5, and 3.0 cm, respectively. The 
depth from the target center to the probe surface varied from 1.0 cm to 2.5 cm in 0.5 cm 
increment. Tomography images are shown in six slices at different depths from 0.5 cm to 
3.0 cm with 0.5 cm increment. The targets are shown at the corresponding depth.  The 
single ROI and the multi-zone ROIs algorithms were used to reconstruct the images as 
shown in Figure 3-2. In the figure, the separation of the two targets is 2.5 cm and target 
center depths are 1.0, 1.5, 2.0 and 2.5 cm, respectively. The images in the left column ((a), 
(c), (e) and (g)) are the reconstructed absorption distributions using the single ROI 
method and the images in the right column ((b), d), (f) and (h)) are the reconstruction 
results using the multi-zone ROIs algorithm. For single ROI method, the reconstructed 
maximum absorption value of the high contrast target was 0.09 cm−1 (36% accuracy), and 
that of the low contrast target was 0.04 cm−1 (57%) at the depth of 1.5 cm; but the 
accuracy could reach 0.17 cm−1 (68%) for the high contrast target and 0.06 cm−1 (86%) 
for the low contrast target when the multi-zone method was used. With respect to target 
resolving capability, the two targets could not be separated using the single ROI method 
when they were deeper than 2.0 cm. However, the targets up to 2.5 cm depth could be 
separated with the guidance of the prior target locations when the multi-zone method was 
used. Briefly, the average reconstruction accuracy of four target separations of the high 
contrast targets using the single ROI method was 36%, 38%, 35% and 33% at 1.0, 1.5,  
55 
(a) (b)
(c) (d)
(e) (f)
(g) (h)
Single ROI Multi-zone
 
Figure 3-2 Simulated absorption maps of two targets of different contrast ( a = 0.25 cm−1 
and a = 0.07 cm−1) separated by 2.5 cm and located at 1.0, 1.5, 2.0, 2.5 cm depth, 
respectively, using single ROI shown in (a), (c), (e) and (g) and multi-zone method shown 
in (b), (d), (f) and (h). For each figure, there were six subfigures reconstructed at different 
depths marked on the figure title. Each subfigure is a spatial x-y image of 9 cm by 9 cm in 
spatial dimensions. The rest of the figures consisting reconstructed absorption maps were 
displayed with the same dimensions as Figure 3-2. 
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2.0 and 2.5 cm center depth, respectively. The average accuracy of the corresponding 
separations was 63%, 67%, 58% and 47%, respectively, using the multi-zone method. A 
23% average improvement was achieved compared with that obtained using the single 
ROI method. To further evaluate the performance of the multi-zone method with targets 
of different contrast, another set of simulation with a = 0.15 cm−1 as the low contrast 
target and a = 0.25 cm−1 as the high contrast target, and 's = 6.0 cm−1 for both was 
performed. For single ROI method, the average reconstruction accuracy of four 
separations was 31%, 46%, 38% and 22% at 1.0 to 2.5 cm center depth, respectively.  
The average accuracy was 41%, 73%, 68% and 44%, respectively, and an average 22% 
improvement was obtained compared with that using the single ROI method. 
To validate the simulation results, a phantom experiment using two 1-cm polyester 
resin spheres with different contrasts was performed. The intralipid solution was used as 
the background. The experiment was designed using similar conditions as the simulation. 
Figure 3-3 shows the reconstructed absorption maps of the two targets which were 
separated by 2.5 cm and located from 1.0 to 2.5 cm center depths. Targets could not be 
resolved when they were located deeper than 2.0 cm if the single ROI method was used 
(Figure 3-3 (e) and (g)), while in the right column (Figure 3-3 (b), (d), (f) and (h)), they 
could be separated at all depths when the multi-zone method was used. The average 
accuracy of four target separations of the high contrast target was 39%, 44%, 41% and 
34% at depth of 1.0, 1.5, 2.0 and 2.5 cm using the single ROI method, respectively, and 
that was 66%, 75%, 64% and 56%, respectively, using the multi-zone method. The 
average improvement was 26%. Both simulations and phantom experiments 
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demonstrated that the multi-zone algorithm could improve the capability of resolving two 
targets with improved quantification. 
(a) (b)
(c) (d)
(e) (f)
(g) (h)
Single ROI Multi-zone
 
Figure 3-3 Phantom experimental results of two targets of different contrast ( a = 0.23 
cm−1 and a = 0.07 cm−1) separated by 2.5 cm and located at 1.0, 1.5, 2.0, 2.5 cm depth, 
respectively, using single ROI shown in (a), (c), (e) and (g) and multi-zone method shown 
in (b), (d), (f) and (h). 
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Figure 3-4 shows the analysis of reconstruction accuracy quantified using accuracy 
versus different depths. The solid curves are for high contrast target using the multi-zone 
method, while the dotted lines are obtained from the single ROI method. The dashed lines 
are for the low contrast target using the multi-zone method. Because of the limited 
resolving ability of the single ROI method for the low contrast target, the accuracy could 
not be accurately measured and therefore no values are given. The 100% is plotted as the 
reference using dash-dot line. Figure 3-4 (a) and (b) show the results of the simulations, 
where (a) corresponds to the two targets with a = 0.25 cm-1 and a = 0.07 cm-1, and (b) 
a = 0.25 cm-1 and a = 0.15 cm-1. Figure 3-4 (c) shows the results of the phantom 
experiments. The improvement of the multi-zone method is shown by its higher 
reconstruction accuracy (solid lines) than that of the single ROI method (dotted lines). 
From the comparison between the figures, one can see that the reconstructed absorption 
values of the high contrast target remain similar and the most accurate reconstructions 
occur at the depth range beyond 1.0 cm and less than 2.5 cm. For the low contrast target 
(true a = 0.07 cm-1), the reconstruction values were around or slightly over the true 
value 100% (Figure 3-4 (a) and (c)). For the medium contrast target (true a = 0.15 cm-1) 
imaged with the high contrast target together, both targets were under reconstructed but 
the medium contrast target had higher accuracy than that of the high contrast target 
(Figure 3-4 (b)). 
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Figure 3-4 Plot of reconstruction accuracy vs. target depths of two targets using single ROI 
and multi-zone method as labeled in the figures. (a) and (b) were from simulations and (c) 
was from experiments. (a) two targets of a = 0.25 cm−1 and a = 0.07 cm−1; (b) a = 
0.25 cm−1 and a = 0.15 cm−1. (c) a = 0.23 cm−1 and a = 0.07 cm−1. 
A clinical example was given to demonstrate the improvement by using the 
multi-zone method. This 52 years old patient had two suspicious lesions as shown in US 
Figure 3-5 (a). When the single ROI was used, two targets of one slightly higher contrast 
(left) than the other (right) showed in the absorption map reconstructed at 780 nm (Figure 
3-5 (b)) and 830 nm (not shown). The calculated maximum absorption coefficients were 
0.13 and 0.10 cm-1, respectively. When the multi-zone method was used, the calculated 
maximum absorption coefficients were 0.22 and 0.12 cm-1 (Figure 3-5 (c)). The 
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calculated maximum tHb concentrations were 80 and 63  mol/Liter by using the single 
ROI method (Figure 3-5 (d)), and 97 and 62  mol/Liter by using the multi–zone method 
(Figure 3-5 (e)). Biopsy results showed that the higher contrast lesion was a ductal 
carcinoma in situ (left in US) and the lower contrast one was a benign fibrocystic lesion. 
 
(a)
(b) (c)
(d) (e)  
Figure 3-5 A clinical example of two different contrast lesions. (a) Co-registered US 
showed two suspicious masses with centers located at 1.2 cm from the skin surface. (b)-(c) 
Optical absorption map reconstructed at 780 nm using (b) single ROI and (c) multi-zone 
method; (d)-(e) Computed total hemoglobin concentration map using (d) single ROI, and 
(e) multi-zone method. 
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3.3.2 Two targets with same contrast  
In this section, the resolving ability of the multi-zone ROIs method in imaging 
clustered tumors with the same contrast was evaluated using simulations and phantom 
experiments. Two small targets of 1.0 cm diameter and same contrast located at the same 
or different depths were characterized. 
In the first set of FEM simulations, two high contrast targets of 1.0 cm diameter 
were imaged. The target center-to-center separations were 1.5, 2.0, 2.5, and 3.0 cm, and 
center depths varied from 1.0 to 2.5 cm. Figure 3-6 shows an example when the two 
targets with 2.5 cm separation are located at same depths from 1.0 to 2.5 cm. A 
comparison of the results in the left column ((a), (c), (e) and (g)) using the single ROI 
method and in the right column ((b), (d), (f) and (h)) using the multi-zone method clearly 
demonstrates that the capability of multi-zone method in resolving two targets is much 
better. Quantitatively, the single ROI method had the best reconstructed absorption value 
of 0.11 cm−1 (44%) at 1.5 cm depth; the resolving ability was diminished when the target 
was deeper than 2.0 cm.  In contrast, the multi-zone method can reach 0.19 cm−1 (76%) 
reconstruction accuracy and extend the resolving ability up to 2.5 cm. The average 
reconstruction accuracy of four different target separations was 33%, 42%, 40% and 27% 
from 1.0 to 2.5 cm center depth, respectively, using the single ROI method. The average 
accuracy was 45%, 74%, 60% and 41%, respectively, using the multi-zone method. An 
average 20% improvement was achieved compared with that using the single ROI 
method. 
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(a) (b)
(c) (d)
(e) (f)
(g) (h)
Single ROI Multi-zone
 
Figure 3-6 Simulated absorption maps of two targets with same contrast ( a = 0.25 cm−1) 
separated by 2.5 cm and located at 1.0, 1.5, 2.0, 2.5 cm depth, respectively. (a), (c), (e) and 
(g) obtained using single ROI and (b), (d), (f) and (h) using multi-zone method. 
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Figure 3-7 Phantom results of two targets with same contrast ( a = 0.23 cm−1) separated by 
2.5 cm and located at 1.0, 1.5, 2.0, 2.5 cm depth, respectively. (a), (c), (e) and (g) obtained 
using single ROI method, and (b), (d), (f) and (h) using multi-zone method. 
Phantom experiments were performed to verify the simulation results. Two high 
contrast phantom targets of 1.0 cm diameter were embedded inside the intralipid solution 
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with the same experimental conditions as the simulation. Figure 3-7 shows one example 
of the phantom targets separated by 2.5 cm at all depths. The average reconstruction 
accuracy was 29%, 37%, 41% and 28% at 1.0, 1.5, 2.0 and 2.5 cm center depth, 
respectively, using the single ROI method and the value was 47%, 84%, 65% and 42%, 
respectively, using the multi-zone method. An average 26% improvement was achieved 
compared with that using the single ROI method. Figure 3-8 plots the accuracy ratio vs. 
different depths. The reconstruction accuracy of the multi-zone method (solid lines) is 
much higher than that of the single ROI method (dotted lines). The more accurate 
reconstruction occurred in depth range beyond 1.0 cm and less than 2.5 cm in both 
simulations (Figure 3-8 (a)) and phantom experiments (Figure 3-8 (b)). 
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Figure 3-8 Plot of reconstruction accuracy vs. target depths of two targets of same contrast. 
(a) Simulation results of two targets of a = 0.25 cm−1, and (b) phantom results of a = 
0.23 cm−1. 
The second set of simulation was performed with two targets located at different 
depths. The two targets were the same as before but one was located at 1.0 cm depth 
while another was at 1.5 cm. Different center-to-center separations of 1.5, 2.0, 2.5 and 3.0 
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cm were simulated and shown in Figure 3-9. None of the images shown in the left 
column ((a), (c), (e) and (g)) obtained from the single ROI method could separate the two 
targets; while the images shown in the right column ((b), (d), (f) and (h)) obtained from 
the multi-zone method could resolve them when the center-to-center separation was 
larger than 2.0 cm. Same as other cases, the reconstructed absorption coefficients were 
more accurate when the multi-zone method was used. The absorption coefficients were 
0.12 (48%), 0.10 (40%), 0.10 (40%) and 0.10 (40%) for 1.5, 2.0, 2.5 and 3.0 cm 
center-to-center separations, respectively, using the single ROI method; and those were 
0.16 (64%), 0.18 (72%), 0.15 (60%) and 0.16 (64%) using the multi-zone method with an 
average 23% improvement. 
To verify the simulation results, phantom experiments were performed using the 
similar condition as the simulation. Two high contrast phantom targets of 1.0 cm 
diameter were located at 1.0 cm and at 1.5 cm center depths. Figure 3-10 shows the US 
and the reconstructed images of the two targets separated by 1.5, 2.0, 2.5 and 3.0 cm.  
The reconstructed absorption coefficients were 0.10 (43%), 0.09 (39%), 0.08 (35%) and 
0.09 (39%) for 1.5, 2.0, 2.5 and 3.0 cm center-to-center separations, respectively, using 
the single ROI method ((a), (c), (e) and (g)); and those were 0.16 (70%), 0.14 (61%), 0.17 
(74%) and 0.15 (65%) using the multi-zone method ((b), (d), (f) and (h)). An average 
29% improvement was achieved compared with that of the single ROI method. When the 
separation of the two targets was larger than 2.0 cm, the multi-zone reconstruction 
method could separate them, but the single ROI method could not. 
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Center-to-center separation: 1.5 cm
Center-to-center separation: 2.0 cm
Center-to-center separation: 2.5 cm
Center-to-center separation: 3.0 cm
(a) (b)
(c) (d)
(e) (f)
(g) (h)  
Figure 3-9 Simulated absorption maps of two targets of same contrast ( a = 0.25 cm−1) 
separated by 2.5 cm with one located at 1.0 cm and another located at 1.5 cm center depths. 
(a), (c), (e) and (g) obtained using single ROI method, and (b), (d), (f) and (h) using 
multi-zone method. 
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Center-to-center separation: 1.5 cm
Center-to-center separation: 2.0 cm
Center-to-center separation: 2.5 cm
Center-to-center separation: 3.0 cm
(a) (b)
(c) (d)
(e) (f)
(g) (h)  
Figure 3-10 Phantom experimental results of two targets of same contrast ( a = 0.23 cm−1) 
separated by 2.5 cm with one located at 1.0 cm and another located at 1.5 cm center depths. 
(a), (c), (e) and (g) obtained from the single ROI method, and (b), (d), (f) and (h) from 
multi-zone method. The corresponding co-registered US images were shown in the first 
column. 
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Figure 3-11 A clinical example of two malignant tumors. (a)-(b) Co-registered US image 
of 9 o’clock lesion and (b) 7-8 o’clock lesion with center location of approximately 2.0 cm; 
(c)-(d) Absorption maps reconstructed at 780 nm using (c) single ROI, and (d) multi-zone 
method; (e)-(f) Total hemoglobin concentration maps using (e) single ROI, and (f) 
multi-zone method. 
A clinical example of 59 year-old woman with two suspicious lesions located at the 
9 and 7-8 o’clock positions is given in Figure 3-11.. US images of the two lesions are 
shown in different views in Figure 3-11 (a) and (b) with the center depth of 2.0 cm 
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approximately. Because the NIR probe is much bigger (9 cm diameter) than the US probe 
(5 cm x 1 cm), the two targets are visible in the absorption maps reconstructed using a 
single ROI at 780nm (c) and 830 nm (not shown). The calculated maximum absorption 
coefficients were 0.18 and 0.14 cm-1 for 9 and 7-8 o’clock lesions, respectively. When the 
multi-zone method was used as shown in (d), the calculated maximum absorption 
coefficients were 0.23 and 0.19 cm-1, respectively. The calculated maximum tHb 
concentrations were 90 and 81  mol/Liter by using the single ROI method, and 105 and 
101  mol/Liter by using the multi–zone method. Biopsy results showed that both 
lesions were invasive carcinomas. 
3.3.3 Large target surrounded by a small satellite target  
(a) (b)
(c) (d)  
Figure 3-12 Simulated absorption maps of one larger target with a smaller target closer to 
its top half ((a) and (b)), and bottom half ((c) and (d)) using single ROI ((a) and (c)) and 
multi-zone method ((b) and (d)). The center to center distance between the two targets was 
3.0 cm. (The arrow head points to the smaller target.) 
70 
Large cancers may have smaller satellite lesions in the neighboring areas. To 
quantify the reconstruction accuracy under this imaging condition, two high-contrast 
targets of 2 cm and 1 cm diameter next to each other were simulated using FEM method.  
Two sets of simulations were performed where the larger target was surrounded by the 
smaller one closer to its top half or bottom half in depth. In the first set of simulations, the 
larger target was located at 1.5 or 2.0 cm center depth and the smaller target located 
closer to its top half with the center-to-center separation of 2.1, 2.5, 3.0 and 3.5 cm, 
respectively. Figure 3-12 (a) and (b) shows the absorption maps of the two targets with 
3.0 cm separation when the larger one is located at 1.5 cm center depth. The 
reconstructed maximum absorption of the larger target using the single ROI method (a) 
was 0.10 cm-1 (40%), and the multi-zone method (b) was 0.16 cm-1 (64%). The smaller 
target was not resolved using the single ROI method (a) and that was 0.09 cm-1 (36%) 
using the multi-zone method (b). More results of different target separations and depths 
are given in Table 3-1. The average reconstruction accuracy of the larger target was 
51.5% and the satellite target could not be resolved until the separation was larger than 
3.5 cm if the single ROI method was used. The accuracy of the larger target could reach 
78.5% using the multi-zone method and the satellite target was visible when the 
separation reached 3.0 cm with the average accuracy of 39%. In the second set of 
simulation, the larger target with the small satellite target closer to its bottom half was 
simulated with 2.1 to 3.5 cm separations and the center depths of 1.5 and 2.0 cm.  The 
reconstructed absorption maps are shown in Figure 3-12 (c)-(d). Using the single ROI 
method, the smaller target could not be resolved and the maximum reconstructed a  
was 0.10 cm-1 (40%) as shown in (c). Using the multi-zone method, the reconstructed 
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maximum absorption of the larger target was 0.15 cm-1 (60%) and that of the smaller one 
was 0.05 cm-1 (20%) (d). The satellite target is visible in (d) but reconstruction accuracy 
(20%) is far lower than that of the larger one. As shown in Table 3-1, the average 
reconstruction accuracy of the larger target is 51.5% using the single ROI method and 
that is 76% using the multi-zone method. The smaller target could not be resolved until 
the target separation reached 3.5 cm using the single ROI method and it could be resolved 
when the separation was larger than 3.0 cm with the average accuracy of 23% using the 
multi-zone method. 
We also performed phantom experiments using two high contrast polyester resin 
spheres. Two sets of experiments were done and the targets were located at the same 
coordinates as used in the simulation described earlier. The left column of the US images 
in Figure 3-13 show the locations of the two targets when they are separated by 3.0 cm, 
and the reconstructed absorption maps are shown in the right column. When the smaller 
target was closer to the top half of the larger one, the reconstructed maximum a  of the 
larger target was 0.09 cm-1 (39%) using the single ROI method (a) and 0.17 cm-1 (74%) 
using the multi-zone method (b), and the maximum a  was 0.11 cm-1 (48%) in (b) of 
the smaller target using the multi-zone method. The reconstructed maximum a  was 
0.09 cm-1 (39%) in (c) using the single ROI method and 0.16 cm-1 (70%) of the larger 
target, and 0.11 cm-1 (48%) of the smaller one in (d) using the multi-zone method when 
the smaller target was located closer to the bottom half of the larger one. The smaller 
target can not be resolved in both (a) and (c). In Table 3-2, the average reconstruction 
accuracy at all separations and depths is 46.7% and 80.5% (larger target) and 26% and 
48% (smaller target) using the single ROI method and the multi-zone method, 
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respectively, when the smaller target is closer to the top half of the larger one. The 
average values are 49% and 78% (larger target) and 24% and 36% (smaller target) when 
the smaller target is closer to the bottom half of the larger one. This set of simulations and 
phantom experiments demonstrated the improvement and limitations when the clustered 
lesions of different sizes were imaged by the multi-zone algorithm. 
(a)
(b)
(c)
(d)  
Figure 3-13 Phantom experiments of one larger target with a smaller target located close to 
its top half ((a) and (b)), and bottom half ((c) and (d)) using single ROI ((a) and (c)) and 
multi-zone method ((b) and (d)). The corresponding co-registered US images were shown 
in the left column. (The arrow head points to the smaller target.)  
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3.4  Discussion and Summary 
We have qualitatively evaluated the performance of the single ROI reconstruction 
method and the new multi-zone reconstruction method with respect to the resolving 
ability and accuracy when multiple targets were present. In general, the single ROI 
method cannot resolve two small targets when their separations were less than 2.5 cm, 
and the target depth was greater than 2.0 cm. The highest reconstruction accuracy of the 
single ROI method for small dual targets was about 50% for high contrast targets. The 
multi-zone reconstruction method improved both the resolving ability and accuracy when 
the priori lesion location information was given. As a result, two targets located at 2.5 cm 
depth with separation greater than 2.0 cm could be distinguished. With respect to 
accuracy at all depths and separations, the multi-zone method improved the accuracy and 
the highest reconstruction could reach 91% for high contrast targets. 
Due to the intense light scattering in a turbid medium, the light quantification of 
targets located at deeper depths of more than 2.5 cm was lower and the resolving 
capability of the multiple targets was poorer. In addition, because the diffusion 
approximation was used in reconstruction and the lacking of the center source, targets 
located at shallower depth were not quantified as accurately as the targets located beyond 
1.0 and less than 2.5 cm depth range. The multi-zone method improved the light 
quantification for smaller 1 cm dual targets of different separations located at all depths 
and the improvement was more dramatic when targets were in the depth range beyond 
1.0 cm and less than 2.5 cm. Another issue is related to the reconstruction accuracy of 
different contrast targets. In this paper, we have three sets of targets which have high 
(0.25 cm-1), medium (0.15 cm-1) and low contrast (0.07 cm-1). Over reconstruction 
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happened more to low contrast target and under reconstruction occurred to high and 
medium contrast targets, however, medium contrast targets had higher reconstruction 
accuracy than that of high contrast targets because of the use of linear Born 
approximation. In clinical studies, multiple lesions located closer to each other is not 
uncommon, a diagnostic modality should be able to characterize multiple lesions more 
accurately. In all simulations and phantom experiments, the multi-zone method achieved 
about 20% improvement compared to that of the single ROI method. Thus, it is more 
accurate in diagnosis of clustered lesions. When two targets one larger and one smaller 
were located closer to each other, the location of the reconstructed absorption mass was 
shifted toward the larger target. A smaller target located more than 3 cm away from the 
larger one may be resolved when the multi-zone algorithm was used, however, the 
reconstruction accuracy was low. Therefore, it is not reliable to use the multi-zone 
method to characterize the clustered lesions with a primary larger tumor that dominates 
the reconstruction. In other words, when the primary tumor is malignant, the smaller 
lesions around it cannot be diagnosed correctly using the diffused optical tomography 
even with a priori target information. 
In summary, we have introduced a new multi-zone reconstruction method and 
compared its performance with the single ROI method. Simulation and phantom studies 
have showed more than 20% improvement in target quantification as compared to that of 
the single ROI method. Clinical examples were given to demonstrate the potential of the 
new method in accurate characterization of the malignant and benign lesions. 
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4 Imaging tumor oxyhemoglobin and deoxyhemoglobin 
concentrations with ultrasound-guided diffuse optical 
tomography 
4.1  Introduction 
Tumor vasculature is directly related to tumor proliferation, growth, and metastasis; 
while tumor hypoxia alters the pattern of gene expression leading to more aggressive 
behavior with increased metastatic potential and treatment resistance.1-11 Tumor oxygen 
partial pressure measurements have shown that hypoxia conditions often exist in 
malignant tumors but not in benign lesions.4, 11 When tumor cells are exposed to chronic 
hypoxia as they outgrow their vascular supply, they develop an adaptation that has a 
negative effect on their response to treatment.2, 5 If the tumor is not well perfused, 
chemotherapeutic drugs cannot easily reach the tumor cells. Furthermore, tumor cells 
rapidly adapt to hypoxia by slowing their growth rate, and conventional chemotherapy 
generally is toxic to cells in proportion to their proliferation Most chemotherapeutic drugs 
are essentially anti-proliferation agents rather than specific anti-cancer agents so that 
when cells enter a resting phase they are insensitive to these cytotoxic agents. Thus, the 
ability to image tumor hypoxia in general has important clinical utility, providing 
additional diagnosis information for distinguishing malignant and benign lesions, 
selection of a cohort of patients who may benefit from hypoxia-directed therapies and 
monitoring tumor response using longitudinal imaging.7 
NIR DOT or Diffuse Optical Spectroscopy (DOS), a non-invasive imaging or 
spectroscopic technique, has demonstrated its clinical potential of probing tumor 
angiogenesis which can be quantitatively assessed by tHb concentration.12-23 When 
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multiple wavelengths are used, DOT/ DOS can be used to map deoxyHb and oxyHb 
concentrations or tumor oxygen saturation. Numbers of publications have reported a 
lower oxygen saturation SO2 in breast tumors with respect to normal tissues,24-26 whereas 
others have observed no difference.27, 28 Publications involving a larger number of 
subjects have shown that oxygen saturation itself may not be a statistically significant 
discriminator to differentiate malignant from benign breast lesions.12, 13, 15, 16, 19, 20  
Chance et al. showed that SO2, when combined with tHb could provide sensitivity and 
specificity of 96% and 93%, respectively, for classifying malignant from benign 
lesions.14 Rinneberg et al. concluded from a study involving 154 patients that the tumor 
SO2 provided additional information in distinguishing malignant from benign breast 
lesions, however, the tumor SO2 itself was a poor discriminator.19 By using x-ray 
tomosynthesis guided DOT, Fang et al. reported lower SO2 in some cancer cases, 
however, the statistically significance of SO2  was found only between cysts and solid 
benign lesions.16 Choe et al. found statistical significance of oxyHb not SO2 in 
differentiating malignant cancers from normal tissues.15 Cerussi et al. reported statistical 
significance of oxyHb and deoxyHb not SO2 in malignant cancers as compared to the 
background normal tissues.13 Using DOS to follow patient response to neoadjuvant 
chemotherapy, Cerussi et al. found that deoxyHb was a significant predictor to treatment 
response.12 
Our group has explored the use of US-guided optical tomography to improve the 
lesion localization and light quantification accuracy.22, 23, 29 In our clinical studies, we 
have observed that large tumors often presented with more deoxygenated center core and 
oxygenated peripheral distribution.30, 31 This type of heterogeneous distribution 
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sometimes can be seen in smaller 1 - 2 cm tumors as well, however, it has not been 
observed in benign lesions. It has been reported in the literature that as a solid tumor 
progresses, tumor angiogenesis produces abnormal vasculature that is characterized by 
hypervascularity at the tumor periphery, where the tumor center can be hypovascular.32 
Peripheral enhancement patterns are frequently used in contrast-enhanced MRI to 
differentiate malignant from benign lesions.33, 34 
This study was motivated by the lack of phantom studies correlating 
inhomogeneous oxygenation distribution with our in vivo observations. Additionally, 
there are no systemic phantom studies quantifying the accuracy of reconstructed 
deoxyHb and oxyHb distributions or oxygen saturation as a function of tumor size and 
tumor depth with different oxygen conditions. In this paper, we have evaluated the 
capability of US-guided DOT in imaging deoxyHb and oxyHb distributions of blood 
phantoms having different controlled oxygen conditions. Different size phantoms located 
at different depths were imaged and the estimated oxygen saturations were compared 
with the measurements obtained using a pO2 electrode. A blood hypoxia phantom with 
deoxygenated core and oxygenated periphery was imaged and the deoxyHb and oxyHb 
distributions correlate with the heterogeneous distributions frequently seen in breast 
cancers. Clinical examples of benign and breast cancer cases are given to demonstrate the 
capability of US-guided optical tomography in mapping heterogeneous deoxyHb and 
oxyHb distributions in breast cancers and in assisting diagnosis. To the best of our 
knowledge, this manuscript is the first to report the utility of US-guided DOT in mapping 
heterogeneous deoxyHb and oxyHb distributions in phantoms and in patients. 
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4.2  Materials and methods 
4.2.1 US guided DOT imaging system and imaging algorithm  
Our frequency domain system consists of 14 parallel detectors and 4 laser diodes of 
740nm, 780nm, 808nm and 830nm. Each laser diode was sequentially switched to 9 
positions on the probe (see Figure 4-1). The center slot on the probe was used for 
ultrasound transducer and the sources and detectors were distributed on both sides. 
Intralipid solution of 0.8% was used to emulate the background tissue and the calibrated 
absorption coefficient ( a ) was in the range of 0.01-0.03 cm−1 and the reduced scattering 
coefficient ( 's ) was in the range of 7-8 cm−1 for the four wavelengths employed. 
Measurements were made with the target inside the intralipid (target data) and intralipid 
alone as a reference. The perturbation between the target data and the reference was used 
for image reconstruction. 
source
detector
 
Figure 4-1 Probe geometry used for phantom experiments. The source and detector pairs 
were distributed between 2 cm to 7.5 cm. Due to saturation of PMT detectors at near 
source-detector pairs, only those pairs with distance greater than 2.5 cm were used for 
imaging reconstruction. 
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The dual-zone mesh scheme introduced by us earlier was used for reconstruction of 
absorption maps.35 Briefly, the imaging volume was segmented into two regions 
consisting of the lesion (ROI) as identified by the co-registered ultrasound and the 
background region. We used a smaller fine mesh size for the lesion region and a larger 
coarse mesh size for the background region, so that the total voxels with unknown optical 
properties was significantly reduced and the inversion converged quickly in three to four 
iterations. The conjugate gradient method was used for the iterative optimization. Using 
this method, the scattered field can be related to the integral or total absorption 
distribution as: 
        
T
BLNMBLMSC MMWWU ],[],[][ 1                                           (1) 
where LW  and BW  are the weight matrices for lesion region and background region, 
respectively; ]')'(,')'([ 3
1
3  
LL N
aaL rdrrdrM  and ]')'(,')'([ 31 3   BB N aaB rdrrdrM   
are the total absorption distribution of the lesion and the background regions, respectively. 
Here, the total absorption distribution was reconstructed rather than )'(ra . At the end 
of the iterative optimization, the total absorption distribution is divided by the different 
voxel sizes of the lesion and background to obtain )'(ra . aaa rr   )'()'( , 
where a  is the background absorption obtained from intralipid for phantom 
experiments and contralateral normal breast for patients. 
Both deoxyHb and oxyHb are the major endogenous chromophores in tissue that 
absorb light in the NIR range. The absorption between 700 nm - 800 nm is dominated by 
deoxyHb and that between 800 nm - 900 nm is dominated by oxyHb (Figure 4-2). The 
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deoxyHb and oxyHb concentrations at each imaging voxel 'r  are related to the 
reconstructed absorption coefficients, )'(ria
 s, by the following equations: 
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where iHb
 and iHbO 2  are extinction coefficients at wavelength i . The deoxyHb and 
oxyHb concentrations were computed as: 
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where wavelengths 1 , 2 , 3 , 4  correspond to 740, 780, 808  and 830 nm, 
respectively. The tHb concentration is computed as: 
        )'()'()'( roxyHbrdeoxyHbrtHb                                  (4)  
and oxygenation saturation as: 
        %100
)'(
)'()'(2 rtHb
roxyHbrSO                                        (5) 
Equation (5) provides oxygen saturation mapping at each voxel 'r , which is not robust at 
the locations where the tHb concentration is low. Therefore, the maps of )'(rdeoxyHb  
and )'(roxyHb  computed from four wavelengths were used to visualize the deoxy- and 
oxy- components of the hemoglobin distribution. Furthermore, the mean values of oxyHb 
and tHb computed within the full width and half maximum from the maximum value of 
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the corresponding distribution were used to obtain the estimated SO2 of phantom targets 
as: 
          
%1002 

totalHbmean
oxyHbmeanSO                                    (6) 
The estimated or computed SO2 was used to compare with measured SO2 obtained from a 
pO2 electrode discussed in the next section. 
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Figure 4-2 Absorption spectra of tissue chromophores in NIR region with highlighted four 
wavelengths used in reported experiments. 
4.2.2 Hypoxia model experiments  
Hypoxia model experiments were performed to validate the accuracy of the tumor 
hypoxia mapping and oxygen saturation quantification using the US-guided DOT 
technique. In the model experiment, blood phantoms at different controlled oxygenation 
conditions were imaged by the combined system. Hollow glass spheres of sizes 1.0 cm to 
3.0 cm (0.5 cm increment) were customized (Glass Technology Center, University of 
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Connecticut, Storrs, CT) to hold the blood samples for mimicking different tumor sizes. 
Blood was collected from 2-3 months old fresh euthanized rats by cardiac puncture and 
preserved in 7.0 ml EDTA tubes (BD Vacutainer, Franklin Lakes, NJ; K3 EDTA 12 mg 
blood collection tubes: 8018346). The blood was centrifuged at 2000 rpm for 15 minutes 
to collect red blood cells (RBC). The supernatants of plasma and serum were aspirated. 
Similar amount of sterile saline solution was added to RBC and centrifuged again until 
the supernatant was clearer. The RBCs were then free from the clotting proteins which 
were originally present in the plasma.36 For the optical imaging experiment, the RBCs 
were diluted 4 times with sterile saline solution and the diluted RBCs were filled in the 
customized glass spheres (2.0 mm openings). The diluted RBCs referred as diluted blood, 
considered as oxygenated blood, were placed in glass spheres and imaged with the 
combined system. 
The diluted blood was deoxygenated by passing nitrogen gas (Airgas East, 
Cheshire, CT) at 1.5 psi for 10 minutes in a tonometer. The deoxygenated blood was then 
transferred to the previously evacuated glass spheres for imaging. Absorption maps were 
reconstructed at four wavelengths with oxygenated and deoxygenated blood phantoms 
located at different depths. Following the collection of one set of data at one 
deoxygenated condition, the blood was transferred to the original tonometer and slowly 
oxygenated by adding small volumes of oxygen and gently shaking it. Using this method, 
different intermediate deoxygenated conditions were achieved. 
We have taken care to avoid the concentration change caused by water evaporation 
during gas bubbling. As explained by Cope et. al.,37 hemoglobin can become denaturized 
and precipitate (produce scattering), if it is deoxygenated vigorously or remains 
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deoxygenated for a long period of time. The concentration change can shift the isobestic 
point to different wavelengths. For deoxygenation, the blood was filled in the tonometer 
sealed with a rubber stopper. Two 18 gage needles were attached to the rubber for inlet 
and outlet of gases. There was an additional port for a pO2 electrode, for measuring 
oxygen saturation. The nitrogen gas was passed to the tonometer at 1.5 psi and the 
tonometer was gently shaked for proper mixing. During gas passing precautions were 
taken not to form bubbles which can evaporate and changes the density of blood hence 
the absorbance. We have observed this effect when the gas was passed vigorously and 
kept the gas passing for a long period of time.  In our procedure we always limited the 
gas passing time to 10 minutes. To bring back to oxygenated blood and for getting 
intermediate oxygen saturation points, air from the environment was injected to the 
tonometer and the tonometer was shaked gently. 
Three different types of model experiments were performed to evaluate our 
approach; (1) same blood phantom with different oxygenation conditions located at 
different depths, (2) blood phantoms of different sizes with similar oxygenation 
conditions, and (3) a smaller target with deoxygenated blood inside a bigger target with 
oxygenated blood. The third set of experiment emulated the condition of a large cancer 
where the core of the tumor could be deoxygenated and periphery was oxygenated. All 
the targets were embedded in a 0.8% homogeneous intralipid medium (Fresenius Kabi, 
Uppsala, Sweden). The intralipid background was first calibrated before imaging the 
targets. The oxygen saturation was also measured by a commercial pO2 electrode 
(DO-166MT-1, Lazar Research Laboratory, CA), and was considered as measured SO2 
throughout the paper. 
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4.2.3 Clinical example  
Clinical experiments were performed at the Health Center of the University of 
Connecticut. The study protocol was approved by the local Institution Review Board 
(IRB) committee. All patients who participated in our study signed the informed consent. 
The patients’ data were taken at the lesion area and the contralateral breast of the same 
quadrant as the lesion. Contralateral data set was used to estimate background optical 
properties for weight matrix computation. The perturbation was computed between lesion 
data and contralateral data and used for image reconstruction. 
4.3  Results 
4.3.1 Model hypoxia experiments  
One set of experiment was done with a 2.0 cm target of different oxygen saturations. 
The target was imaged at depths from 1.5 cm to 3.0 cm with 0.5 cm increments. From the 
NIR optical spectrum of chromophores,38 it is well known that oxyHb and deoxyHb show 
significant differences in absorption coefficients at 740 nm and 830 nm. The 
reconstructed absorption images at four wavelengths, tHb, oxy- and deoxy- hemoglobin 
concentrations, for an oxy- and deoxy- blood phantom are shown in Figure 4-3 (A) and 
(B), respectively. The colorbar represents the hemoglobin concentration in µM. The 
maximum absorption coefficients reconstructed at four wavelengths for both oxy- and 
deoxy- blood located at 2.0 cm depth is shown in Figure 4-3 (C), which is in accordance 
with the standard NIR spectrum. 38 The isobestic point was estimated around 798 nm. 
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(a) 740 nm (b) 780 nm
(c) 808 nm (d) 830 nm
(e) tHb Concentration (f) Oxy-hemoglobin
(g) Deoxy-hemoglobin
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(a) 740 nm (b) 780 nm
(c) 808 nm (d) 830 nm
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(e) tHb Concentration (f) Oxy-hemoglobin
(g) Deoxy-hemoglobin
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Figure 4-3 (A) (a)-(d) Reconstructed absorption maps for target of SO2 = 92% at different 
wavelength of 740 nm (a), 780 nm (b), 808 nm (c), and  830 nm (d), respectively. (e) tHb, 
(f) oxyHb (g) deoxyHb. Each map has 7 sub-images. Each sub-image shows a spatial x-y 
absorption distribution at the corresponding depth marked on the title of the sub-image. 
The depth increment is 0.5 cm. The dimensions of the sub-image are 9 cm by 9 cm. In the 
following figures, the dimensions of the absorption and hemoglobin maps are the same as 
Figure 4-3 (A). In addition, the color bars for absorption coefficients were from 0 to 0.22 
cm-1; and the values for hemoglobin concentrations were from 0 to 100 µM unless noted in 
the figure caption. (B) Reconstructed absorption maps for target of SO2 = 31% at different 
wavelength of 740 nm (a), 780 nm (a), 808 nm (a), and  830 nm (a), respectively. (e) tHb , 
(f) oxyHb (g) deoxyHb. (C) Measured absorption coefficients at 4 wavelengths under two 
different oxygen conditions. The isobestic point is estimated at 798 nm. 
In this set of experiments, we used equation (6) to estimate the average oxygen 
saturation from the reconstructed absorption maps and referred it as estimated SO2. The 
target oxygen saturation was also measured by the SO2 meter prior to and 
post-experiment and the former measurements were taken as measured SO2. The target 
oxygen saturation was varied from 14 % to 92 %. The estimated SO2 verses the measured 
SO2 of a 2.0 cm target located at different experimental depths is plotted in Figure 4-4. 
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The experiments, with different sets of phantoms, were repeated at a different day to 
evaluate the consistency of our procedures and variations related to environmental pO2, 
and both results are plotted as ‘day: 1’ and ‘day: 2’. The estimated values matched well to 
the measured values (solid dark line) when the targets were at depths of 2.0 and 2.5 cm 
and the SO2 was within 14-89%. The absolute deviations in the estimated SO2 from the 
measured values were within 7 % (mean error of 3.5% over all the saturation ranges). 
The deviations were higher when the targets were at shallower depths (1.5 cm) and 
deeper (3 cm) from the probe. At 1.5 cm depth, the measurement deviations were from 0 
to 7% with one exception of 11% deviation at 89% measured SO2, where as for deeper 
targets (3.0 cm), the deviations were from 2-8% (mean error of 5.5% over all the oxygen 
saturation ranges). It is noted here that, the errors were larger in reconstructed SO2 if the 
oxygen saturation was less than 10% (not shown in the figure). This problem was earlier 
observed in theoretically generated data (large estimation errors for SO2 < 30%) by 
Heffer et. al.39 and experimentally blood phantom data by McBride et. al.38 and 
Srinivasan et. al.25 (oxygen saturation was accurate to within 15% for pO2 < 20 mmHg). 
We have studied the effects of target size on SO2 estimation. This set of experiment 
mimicking different development stages of breast tumors. To model this process, glass 
spheres of diameters from 1.0 cm to 2.5 cm in 0.5 cm increments were imaged at 
different oxygenation conditions. The top portions of the targets were placed at 1.0 cm 
depth from the probe. The measured oxygen saturations for targets of different sizes at 
two different oxygenation conditions are shown in Figure 4-5. The reconstructed values 
were very close to that of measured values with absolute deviations of 1-5% for 14% 
measured SO2 and 1-8% for 70% measured SO2. The deviations between reconstructed 
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and measured SO2 values were the least for targets of 1.5cm and 2.0 cm, and the 
deviations were slightly higher for 1.0 cm and 2.5 cm targets. From Figure 4-5, it is noted 
that the SO2 is over estimated for deoxy-targets and underestimated for oxy-targets. For 
the deoxy-targets, the deoxy-hemoglobin is slightly underestimated because the power of 
740nm laser diode in our system is about 60% of that at other three wavelengths. The 
underestimation of deoxy-hemoglobin causes overestimation of SO2 (see equation 6).  
For the oxy-targets, the oxy-hemoglobin is underestimated because stronger absorption at 
808 nm and 830 nm (dominated by oxy-absorption) causes the saturation in the 
reconstructed target absorption maps when Born approximation is used. 
 
Figure 4-4 Measured oxygen saturation versus estimated oxygen saturation obtained using 
equation (6). The 2.0 cm target was located at different depth. 
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Figure 4-5 Target size versus estimated SO2 obtained at two oxygen saturation conditions. 
 
Figure 4-6 Sketch of the concentric target and experimental set-up. 
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To emulate the real clinical scenario where the core of the large tumor could be 
hypoxic, we have made a phantom with a 4.0 cm diameter ball (2.2 cm opening) filled 
with oxygenated blood. A smaller 2.0cm diameter ball filled with deoxygenated blood 
was placed inside the bigger ball (see Figure 4-6). The thickness between the outer shell 
and the inner core was 0.5 cm. In our previous study of imaging inhomogeneous or 
heterogeneous absorbing targets,40 we found that when the thickness between the outer 
shell and the inner core was less than 1.0 cm and the targets located between depth range 
of 1-3 cm, the inner core could be visualized. However, when the thickness was larger 
than 1 cm, the inner core could not be resolved, even the core diameter was relatively 
large. This is caused by the increased scattering events when photons pass the outer shell 
of more than 1.0 cm thick and the information loss between the two groups of photons 
passing outer shell only and passing the outer shell and the inner core. The filled smaller 
ball was mounted on an 8.0 cm long thin transparent glass rod and introduced into the 
bigger ball. The 4.0 cm bigger ball was filled with oxygenated blood. A transparent 
plastic cap with center hole was used to seal the bigger ball. The plastic cap had a 
transparent ventilated extension (a hollow glass cylinder) at the center, some part to 
inside and remaining to outside of the bigger ball, helped guiding the smaller ball to stay 
at the center of the bigger ball. The smaller ball was at the center of the bigger ball when 
the thin transparent glass rod holding the smaller ball was well fitted inside the 
transparent ventilated cylindrical extension of the bigger ball. Based on the length of the 
glass rod coming out of the whole assembly, we were able to control the gap between the 
top surfaces of the bigger and smaller balls. Ultrasound images were taken to estimate the 
exact gap between the balls. The measured SO2 of the outer target was 70% and that of 
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the inner target was 14%. The 4.0 cm oxy-target was imaged first, and a 2.0 cm 
deoxy-blood target was introduced after and the combination was imaged again. 
The absorption images of the 4.0 cm oxy-target are shown in Figure 4-7 (A) (a-d). 
Since light at 830 nm is absorbed more by oxy-hemoglobin and light at 740 nm is 
absorbed more by deoxyHb, the 830 nm image (Figure 4-7 (A) (d)) shows highest 
contrast and the reconstructed images at all wavelengths show one target. The combined 
target image at 740 nm (Figure 4-7 (B)) shows that the core has higher absorption than 
the periphery and the image at 830 nm shows that the periphery is higher than the core. 
The tHb, oxyHb and deoxyHb maps are shown in Figure 4-7 (B) (e)-(g), where the 
colorbar represents the hemoglobin concentration in µM. As seen from the maps, the 
center is higher in deoxyHb map and the periphery is higher in oxyHb map. The 
quantitative SO2 using equation 6 is calculated as 64.2%, however, it is not accurate 
because the distributions of hemoglobin (total, oxy-, deoxy-) are not homogeneous. The 
maxima of total, oxy- and deoxy- hemoglobin concentrations were 58, 46 and 25 µM. 
The maximum was measured at the periphery in total and oxyHb maps and at the core in 
the deoxyHb map. This example demonstrates that our four wavelength imager is capable 
of mapping out inhomogeneous oxyHb and deoxyHb distributions of the target. 
4.3.2 Clinical examples  
The first clinical example is shown in Figure 4-8. The patient is a 26-years-old 
woman having a suspicious solid mass measured 2.2 cm (lateral) x 1.5 cm (depth) by US 
(a). Near infrared and ultrasound scans were performed before her core biopsy and biopsy 
result revealed a benign fibroadenoma. The distributions of absorption maps are quite 
homogeneous for all wavelengths with increasing absorption from 740 to 830nm (not 
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shown). The reconstructed maximum absorption coefficients were 0.11, 0.13, 0.15, and 
0.16 cm-1 at 740, 780, 808 and 830nm, respectively. The computed tHb, oxyHb and 
deoxyHb maps are shown in Figure 4-8 (b)-(d). The color bar is in µM from 0 to 100 µM. 
The reconstructed maximum and mean tHb were 70.6 µM and 42.2 µM. The lesion is 
highly oxygenated which can be seen from oxyHb and deoxy maps. Quantitatively, the 
reconstructed maximum and mean oxyHb were 56.5 µM and 34.8 µM, and 
corresponding values for deoxyHb were 14.7 µM and 9.0 µM. The estimated SO2 was 
83%. It is noted that when the absorption maps are homogeneous, the sum of maximum 
and mean oxyHb and deoxyHb are approximately equal to maximum and mean tHb. 
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Figure 4-7 (A) (a)-(d) Reconstructed absorption maps of the 4.0 cm oxy- target at four 
wavelengths of 740 nm (a), 780 nm (b), 808 nm (c), and 830 nm (d), respectively. The 
color bars for absorption coefficients were from 0 to 0.12 cm-1. (B) (a)-(d) Reconstructed 
absorption maps of the concentric target at four wavelengths of 740 nm (a), 780 nm (b), 
808 nm (c), and  830 nm (d), respectively. (e)-(g) tHb, oxyHb, and deoxyHb maps of the 
concentric target, respectively. The color bars for absorption coefficients were from 0 to 
0.14 cm-1; and the values for hemoglobin concentrations were from 0 to 70 µM. 
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Figure 4-8 Clinical example of a benign fibroadenoma. (a) Co-registered US showed a 
suspicious 2 cm solid mass on the right breast of a 26-years-old woman. (b)-(d) computed 
tHb, oxyHb and deoxyHb maps. The absorption maps at all wavelengths (not shown) and 
computed hemoglobin concentration maps were homogeneous. 
The second clinical example of a stage I breast cancer is given in Figure 4-9 (a).  
This 61-year old woman had a suspicious 1 cm mass seen by US on her left breast. Near 
infrared and ultrasound scans were performed before her core biopsy and biopsy result 
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revealed an intermediate grade invasive carcinoma with ductal and lobular features. The 
reconstructed absorption maps of 740-808 nm are quite homogeneous, while the 
distribution of 830 nm shows higher absorption at the periphery (not shown). The 
computed tHb, deoxyHb and oxyHb maps are shown in Figure 4-9 (b)-(d). As seen from 
the deoxyHb and oxhHb maps, the tumor core is more deoxygenated and the periphery is 
more oxygenated. The computed maximum and mean of tHb, deoxyHb, and oxyHb were 
99.9 µM and 71.3 µM, 61.8 µM and 42.7 µM, 45.3 µM and 33.5 µM, respectively. The 
estimated SO2 was 60% which was much lower than the benign case. It is noted that 
when the absorption maps are inhomogeneous, the sum of maximum oxyHb and 
deoxyHb may not approximately equal to maximum tHb, because maximum values of 
these maps may appear at different spatial locations.  The sum of mean values of oxyHb 
and deoxyHb may or may not equal to mean of tHb depending on the spatial distributions 
of deoxyHb and oxyHb masses. 
The third clinical example of an advanced breast cancer is shown in Figure 4-10. 
This 64-years-old woman had a highly suspicious 5 x 4 cm mass on her right breast 
measured 5 cm (lateral) x 3 cm(depth) by ultrasound (a) and 3.9 cm (cranial caudal) x5.5 
cm (transverse) x4.3 cm (anterior-posterior) by contrast enhanced MRI (b). MRI showed 
periphery enhancement. Near infrared and ultrasound scans were performed before her 
core biopsy and biopsy result revealed an advanced high grade infiltrating carcinoma. 
The reconstructed absorption maps at 740 nm shows higher absorption at the core, while 
830nm map shows higher absorption at the periphery. The 780nm and 808nm show 
absorption distributions between 740 nm and 830 nm. The 360 reconstructed maximum 
absorption coefficients were 0.19, 0.13, 0.13, and 0.25 cm-1 at 740, 780, 808 and 830 nm, 
102 
respectively. The computed tHb, oxyHb and deoxyHb maps are shown in Figure 4-10 
(c)-(e). The color bar is in μM from 0 to 70 μM. The oxyHb map showed periphery 
distribution, while the deoxyHb map showed higher value at the core. The maximum 
total hemoglobin concentration was 82.6 μM measured at periphery. The maximum 
oxyHb and deoxyHb were 56.4 μM and 39.8 μM measured at periphery and core 
respectively. The mean values of tHb, oxyHb, and deoxyHb were 52.5, 35.2 and 27.4 μM 
and estimated SO2 was 67%. This example demonstrates the unique tumor vasculature 
and oxygen consumption patterns that can be revealed by our US-guided DOT. 
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Figure 4-9 Clinical example of a stage I breast cancer. (a) Co-registered US showed a 
suspicious 1 cm mass on the left breast of a 61-years-old woman. (b)-(d) computed tHb, 
oxyHb and deoxyHb maps. The absorption maps of 740nm, 780nm and 808nm are quite 
homogeneous, however, the map at 830nm shows more periphery distribution (not shown). 
As a result, the computed oxyHb shows more periphery distribution. 
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Figure 4-10 Ultrasound image of an advanced breast cancer located at the right breast of a 
64-years- old woman (a), and MRI image of the cancer (b) marked by the arrow head. (c)-(f) 
computed 600 tHb, oxyHb, and deoxyHb maps, respectively. The absorption map at 
740nm shows higher value at the core; while the absorption at 830nm reveals higher value 
at periphery (not shown). As a result, the deoxyHb shows a higher value at the core and 
oxyHb map reveals periphery distribution. The color bars for hemoglobin concentrations 
are from 0 to 70 μM. 
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4.4  Discussion and Summary 
We validated the US-guided optical tomography with hypoxia model experiments 
using blood phantoms of different oxygenation conditions, targets of different sizes 
mimicking different developmental stages of breast tumors. The estimated SO2 was 
within 92-100 % of the measured SO2 by using an invasive pO2 electrode as a standard. 
An inhomogeneous concentric blood phantom of deoxygenated center core and 
oxygenated outer shell was imaged and deoxyHb and oxyHb maps revealed 
corresponding distributions which correlate with inhomogeneous deoxy- and oxy- 
distributions frequently seen in large breast cancers. Our results suggest that in addition 
to quantitative tHb concentration, tumor oxyHb and deoxyHb distributions can add more 
diagnostic information for distinguishing malignant from benign breast lesions. Our 
initial findings will need to be further validated by a larger patient population. 
From the reconstructed optical absorption maps at four wavelengths, we were able 
to estimate SO2 in addition to tHb accurately. Compared with using two wavelengths of 
780 nm and 830nm, the target deoxyHb and oxyHb maps obtained from the selected four 
wavelengths were more robust. There are several factors that may affect the estimated 
SO2 obtained from reconstructed absorption maps. Because Born approximation was 
used, the target absorption coefficient could be under reconstructed due to saturation at 
the wavelength where the absorption was high under certain oxygen conditions. For 
example, for oxygenated blood, the reconstructed target absorption was higher at 808 nm 
and 830nm. The under reconstruction of target absorption at these wavelengths may 
cause under estimation of SO2. For the diluted blood we used, the larger error up to 8% 
occurred at higher SO2 end beyond 70%. The experimental errors in measuring oxygen 
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saturation include the time gap between the DOT experiments and SO2 measurement by 
electrode. There might be a minor change in oxygen saturation during this time frame. 
Small reflections from the transparent glass balls might have slightly changed the 
absorption coefficients causing some minor errors in SO2 estimation. We have conducted 
testing with thin transparent balloons, transparent gloves, thin glass balls, and thin clear 
plastics, but the transparent glass balls were easier for mounting and controlling the 
oxygenation level while maintaining lower material effect on image reconstruction.  
Some numbers of RBCs might have died during all the procedures and getting the 
intermediate SO2s, causing different SO2 in blood environment and RBC molecules. The 
electrode measured SO2 of any whole or diluted blood was always less than 92%. By 
nitrogen passing, we were able to bring the oxygen saturation up to 6%, however our 
reconstructed optical absorption coefficients never estimated any SO2 less than 14 % for 
any measured SO2 at any depths and any target size.  This might be due to the relative 
lower power of our 740nm source than that of the other three wavelengths. 
In summary, we have demonstrated the utility of US-guided diffuse optical 
tomography for mapping tumor deoxyHb and oxyHb concentrations in blood phantoms 
and in in-vivo patients. Targets of different sizes and located at different depths with 
different oxygen conditions were used to validate the accuracy of oxygen saturation 
estimation. The absolute deviations between the estimated hemoglobin oxygen 
saturations obtained from reconstructed absorption maps and oxygen measurements 
obtained using a pO2 electrode were less than 8% over the measured range of oxygen 
saturation.  An inhomogeneous concentric blood phantom of deoxygenated core and 
oxygenated outer shell was imaged and deoxyHb and oxyHb maps revealed 
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corresponding distributions which correlated well with inhomogeneous deoxy- and oxy- 
distributions frequently seen in breast cancers. Such distributions may reveal 
hypovascular core and hypervascular peripheral enhancement that correspond to tumor 
angiogenesis development. 
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5 Targeting Tumor Hypoxia with 2-Nitroimidazole-ICG 
dye Conjugates 
5.1  Introduction 
Tumor hypoxia is a major indicator of cancer resistance to chemotherapeutic 
drugs.1 Non-invasive imaging of tumor hypoxia has important clinical utility in predicting 
cancer treatment outcomes and offers the possibility of tailored chemotherapeutic 
regimens that may enhance the probability of complete tumor remission.  
Nitroimidazoles are a well studied class of molecular probes that target tumor hypoxia by 
nucleophilic covalent binding to proteins in environments of low pO2 (<1.5% O2).2-4 
Among all the imidazole compounds, 2-nitroimidazoles have higher electron affinities 
and are the most commonly used hypoxia markers when labeled with positron emission 
tomography (PET) radionuclides.5, 6 Problems associated with PET radionuclides include 
low resolution, high background counts and the use of radioactive tracers. In addition, 
PET systems are expensive for routine clinical use in longitudinal imaging assessments 
over the course of chemotherapy, thus there is a need for the development of safer, 
alternative techniques for imaging tumor hypoxia and improving cancer patient 
outcomes.  
The development of fluorescence diffused optical tomography (FDOT) techniques 
in the near infrared (NIR) spectrum is expected to have significant impact on future 
personalized oncology treatments owing to the very low tissue autofluorescence and high 
tissue penetration depth in the NIR spectrum window.7-9 Cancer NIR molecular imaging 
relies greatly on the development of stable, highly specific and sensitive molecular 
probes.10-15 Organic dyes such as indocyanine green have been used as non-targeted 
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agents for optical imaging of cancer and have been used clinically for many years.16, 17 
By combining these two molecules we have developed a novel nitroimidazole 
indocyanine dye conjugate (2-nitroimidazole-ICG dye conjugate) for tumor-targeted 
hypoxia fluorescence tomography.18 The bis-carboxylic acid ICG derivative was 
synthesized and used in our studies (hereafter cited as ICG).  The 2-nitroimidazole-ICG 
dye conjugate hypoxia probe has been evaluated in vitro using tumor cells and in vivo 
using a mouse tumor model to confirm the capability of the novel probeto target and 
identify hypoxic environments.19 In vivo tumor targeting studies in mice showed that the 
fluorescence signals measured at the tumor site were twice those at the normal site after 
150 minutes post-injection of the hypoxia probe. The fluorescence signals measured after 
injection of ICG alone were the same at the tumor and normal sites indicating a lack of 
tumor targeting and further proving the importance of the 2-nitroimidazole. In vivo 
fluorescence tomography images of mice injected with the hypoxia probe showed that the 
probe remained for more than 5-7 hours in the tumors, however, the images of mice 
injected with ICG confirmed that the unbound dye washed out in less than 3 hours. These 
findings were supported with fluorescence images of histological sections of tumor 
samples using a commercial infrared scanner and immunohistochemistry to 
independently identify tumor hypoxia.  In this paper, we report on the synthesis of a 
second generation 2-nitroimidazole-ICG conjugate using a more stable piperazine linker 
to conjugate the 2-nitroimidazole and bis-carboxylic acid ICG 
(piperazine-2-nitroimidazole-ICG) moieties.  We have compared the performance of the 
second generation hypoxia probe with the earlier version and systemically evaluated its 
sensitivity in an in vivo murine tumor model with tumors located at depths of 1.5 and 2 
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cm inside turbid medium emulating biological tissue.  These studies demonstrate that 
the new piperazine linker significantly improved in vivo fluorescence signal strength 
relative to that of the first generation dye synthesized with an ethanolamine linker 
(ethanolamine-2-nitroimidazole-ICG). 
 
Figure 5-1 Synthesis Scheme 1. 
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5.2  Materials and Methods 
5.2.1 Synthesis of 2-nitro-ICG dye conjugates  
The details of the synthetic procedures used to prepare the dye conjugates, as well 
as the photophysical and chemical properties and the optical stability of the first 
generation dye, ethanolamine-2-nitroimidazole-ICG (compound 4), and related 
compounds have been previously described.18 Briefly, as shown in Error! Reference 
source not found., the methyl 2-nitroimidazoleacetate (compound 1) was coupled to 
ethanolamine to give 2.  Subsequent dehydrative coupling with indocyanine 
dicarboxylic acid 3 gave 4. This work describes the preparation of 2, the synthesis of 3, 
and coupling procedures to prepare 4. Both the bis-carboxylic acid ICG derivative and 
the 2-nitroimidazole-ICG have an absorption peak at 755 nm, and a fluorescent emission 
peak at 778 nm, with a quantum yield of 0.066, which is 5.5 times higher than that 
commercially available ICG purchased from Sigma-Aldrich. For the studies described in 
this manuscript, the synthesis was modified to change the ethanolamine linker to a 
piperazine linker. This modification of the original sequence gave compound 9 (see 
Figure 5-2). The goal of this modification was to produce a dye-conjugate that was more 
robust in vivo, with two amide linkages rather than an amide and an ester. As shown in 
Figure 5-2, the synthesis of compound 9 began by the preparation of the Boc protected 
piperazine in 35% yield using a literature procedure.20 Subsequent treatment with 
bromoacetyl bromide gave compound 6 in 81% yield, and subsequent coupling to 
2-nitroimidazole21 gave 7 in 94% yield. Deprotection of Boc group with TFA gave 
trifluoroacetyl salt 8 in 86% yield, which was coupled to ICG-bis(carboxylic acid) 3 by 
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the same coupling procedure used to prepare 4,22 giving 2-nitropiperazine ICG dye 
conjugate (9) in 21% yield based on 3. 
 
Figure 5-2 Synthesis Scheme 2. 
The piperazine-2-nitroimidazole-ICG, ethanolamine-2-nitroimidazole-ICG and 
bis-carboxylic acid ICG were spectrally characterized by using an UV-Vis 
spectrophotometer and a fluorescence spectrophotometer (Varian Analytical Instruments, 
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Walnut Creek, CA). The wavelength range of both spectrophotometers is 250 nm-1100 
nm. The relative quantum yield of each dye was calculated as Φx = ΦST 
(Gradx/GradST)(ηx2/ ηST2),23, 24 where Grad was the gradient or slope from the plot of the 
integrated fluorescence intensity vs. absorbance measured at different concentrations, x is 
any unknown dye and ST is the standard dye, η is the refractive index of the solvent. ICG 
from Sigma-Aldrich of quantum yield 0.012 25 was used as a standard. The excitation 
wavelength of 755 nm was used for all quantum yield measurements. Since the standard 
and unknown dyes were measured in the same solvent, so the refractive index effects 
were canceled. All the dyes were measured at very low concentration to avoid the 
self-quenching effects. The extinction coefficient of each dye was measured using a 
certain amount of dye powder weighed and diluted in known volume of sucrose solution 
to maintain a fixed concentration (µM/l). The sample path length was 10 mm. The 
absorbance was measured in the UV-Vis Spectrophotometer and Beer-Lambart’s law was 
used to calculate the extinction coefficient from the peak absorbance of the dye with a 
known concentration. The optical properties of all the compounds are given in Table 1. 
Table 1   The optical  properties of commercial Sigma-Aldrich ICG, bis-carboxylic acid 
ICG, ethanolamine-2-nitroimidazole-ICG and piperazine-2-nitroimidazole-ICG 
Compound max
abs  (nm) maxems  (nm) Extinction 
Coefficient 
ε(M-1cm-1) 
Quantum Yield (Ф)
ICG from 
Sigma-Aldrich 
780 807 115000 0.012 
bis-carboxylic  
acid ICG 
755 790 220920 0.0659 
ethanolamine-2- 
nitroimidazole-ICG 
760 790 159141 0.0590 
piperazine-2- 
nitroimidazole-ICG 
760 790 229543 0.0717 
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5.2.2 Murine Tumor Model  
In vivo tumor imaging experiments were performed using a murine tumor model 
(4T1 Luc mouse mammary carcinoma cells grown in BALB/c mice). The animal 
protocol was approved by the Institutional Animal Care and Use Committee of 
University of Connecticut. 4T1 Luc cells were cultured at 37◦C with 5% CO2 in RPMI 
1640 medium (Gibco, USA), supplemented with 10% FBS, 50 U/mL 
penicillin/streptomycin, 2mM l-glutamine, and 1 mM pyruvate. The 4T1 Luc cells were 
passaged 3 times at 70-80% confluence in a T75 flask (BD Biosciences, Bedford, MA) 
prior to injection. 1 x 105 cells were injected into the lower right mammary fat-pad of 7 
week old BALB/c female mice. The experiments were performed when the tumor sizes 
reached approximately 7-9 mm in diameter, 2-3 weeks post-innoculation. Because tumor 
hypoxia environment depends largely on tumor size,26 the hypoxia conditions for 
different groups of mice injected with different dyes should be statistically similar. 
5.2.3 FDOT system and tumor imaging  
The in vivo experiments were performed using a frequency domain fluorescence 
imaging system which consisted of 14 parallel detectors and 4 laser diodes of 690, 780, 
808 830 nm. Each laser diode was sequentially switched to nine positions on a hand-held 
probe (see Figure 5-3). 690 nm was used as the excitation wavelength in this study. The 
14-channel parallel detection system has two modes: fluorescence mode and absorption 
mode. The two modes can be easily switched by moving a mechanical handle. A stopper 
was designed in the system to ensure a precise optical collimation when switching 
between these two modes. Note that in the fluorescence mode, a bandpass filter was 
placed in the light path to remove the excitation and stray light; in the absorption mode, 
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the bandpass filter was moved out of the light path. 14 photomultiplier tubes were used as 
detectors, and the received signals were amplified by preamplifiers, mixed by mixers, 
low pass filtered, and further amplified before analog to digital converters. Two National 
Instrument data acquisition cards of 8-channel each were used to acquire FDOT data. 
 
Figure 5-3 In vivo fluorescence imaging set-up 
One group of mice was injected intravenously through retroorbital injections with 
100 µl of ICG (n=4 mice) at 50 and 25 µM concentrations, respectively, as control, and 
the second group was injected with 100 µl of piperazine-2-nitroimidazole-ICG at 50 
(n=2), 25 (n=3) and 15 (n=3) µM concentrations, respectively. The last group was 
injected with 100 µl ethanolamine-2-nitroimidazole-ICG at 50µM concentration (n=2) 
and 25 µM (n=2) to compare with results obtained from 
piperazine-2-nitroimidazole-ICG. 
Each mouse, anesthesized with inhalation of 1.5% isoflurane, was mounted on a 
thin glass plate facing the probe with the lower mammary pads submerged in the 
Intralipid solution with a typical soft tissue absorption coefficient a = 0.02-0.03 cm−1 
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and reduced scattering coefficient 's = 6-8 cm−1. The tumor was imaged for up to 1 
minute post-injection and again at 15 minutes, 30 minutes, 1, 2, 3, 5 and 7 hours. The 
center of the probe was aligned to the center of the tumor and the separation between the 
tumor center and the probe surface was defined as the imaging depth for fluorescence 
images. Several imaging data sets were collected to compare the in vivo imaging 
sensitivity of two hypoxia dye conjugates vs. ICG at different concentrations and tumors 
located at different depths. 
5.2.4 Fluorescence imaging reconstruction  
To reconstruct fluorescence images, the normalized Born approximation has been 
widely used.27, 28 This normalization eliminates unknown system parameters, i.e., source 
strengths, gains of different detectors, background optical properties of the tissue, 
coupling efficiency to the tissue, etc. This normalized Born ratio was adopted in our early 
study15 and this study and is given as: 
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  , 
where nB  is the normalized Born ratio, fl  is the fluorescence measurement after 
subtraction of the system noise measurement without any fluorophores or targets in the 
background medium, and exc  is the excitation measurement at 690 nm. For inversion, a 
dual-zone mesh method was used to reconstruct the fluorophore concentrations at the 
target depth and the background regions described previously.15 
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5.2.5 Immunohistochemistry (IHC)  
Hypoxyprobe™-1 plus kit from HPI Inc, was used to visualize the hypoxia tumor 
areas using an IHCtechnique. Based on the protocol recommended by the company, 45 
minutes before the animal was euthanized, 1.5 mg of HypoxyprobeTM-1 plus kit diluted 
in 100 μl of 0.9% saline solution was injected intravenously. Immediately after the 
animal was euthanized, the tumor was harvested. The tumor specimens were collected 
and directly frozen in liquid nitrogen until cryosectioned into 10 μm sections. The 
prepared sections were stored in -80 ◦C before staining. After thawing, the sections were 
fixed in cold acetone for 10 minutes. Sections were rinsed and incubated overnight at 4◦C 
with rabbit anti-pimonidazol antisera PA2627 diluted 1:20 in PBS containing 0.1% 
bovine serum albumin and 0.1% Tween 20. The sections were then incubated for 60 
minutes with FITC-conjugated goat anti-rabbit antibody. Between all steps of the staining 
procedure, the sections were rinsed three times with PBS for 5 minutes each. 
Digital images of the stained sections were obtained using an optical microscope at 
40× and 400× magnifications. The percentage of hypoxic areas was analyzed using the 
ImageJ program (National Institutes of Health, Bethesda, MD, http://rsb.info.nih.gov/ij/). 
For this purpose, obtained digital images were transferred to the ImageJ software and all 
color images were converted to the grayscale. Automated routine was used to threshold 
the images (same threshold for all mice images). The polygon selection tool was used to 
delineate the boundaries of the hypoxic areas. The percentage of hypoxia was defined as 
the number of pixels above the threshold in hypoxic areas over the total number of pixels 
of the total area analyzed. 
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5.2.6 Fluorescence images of tumor samples  
To validate the in vivo FDOT imaging results, excised tumor samples were imaged 
using a commercially available Odyssey Imaging system (Li-COR Biosciences, 
Nebraska). 10 μm tumor sample sections were dried and imaged using this system at the 
highest scan resolution available (i.e. 21 μm). The excitation channel selected was 785 
nm and emission was 820 nm with a bandwidth of 40 to 50 nm. The images were 
obtained using the analysis software provided by the company. The mean pixel value of 
the images including the entire tumor sample area was measured using Image J.29 
5.2.7 Experimental details on the synthesis of the dye-conjugates  
All chemicals were used as received from Aldrich or Acros. All glassware was 
flame-dried under vacuum, and all reactions in organic solvents were performed under a 
nitrogen atmosphere, unless otherwise noted. All solvents were dried according to 
standard procedures. THF was distilled from sodium benzophenone ketyl, methylene 
chloride was distilled from calcium hydride, and dimethylformamide was vacuum 
distilled from calcium hydride. Thin-layer chromatography was done on Sorbent 
Technologies aluminum-backed TLC plates with fluorescent indicator and 0.2 mm silica 
gel layer thickness, and either p-anisaldehyde or phosphomolybdic acid were used as 
developing agents. Column chromatography was done using 60 Å porosity, 32-63 µm 
silica gel. Both 1H and 13C NMR spectra were collected on a Brüker Avance 300 (300.13 
MHz 1H, 75.48 MHz 13C), Brüker DRX-400 (400.144 MHZ 1H, 100.65 MHz 13C) or a 
Brüker Avance 500 (500.13 MHz 1H, 125.65 MHZ 13C). Chemical shifts are given in 
ppm (), downfield from TMS in the following format: chemical shift, multiplicity 
(s=singlet, d=doublet, t=triplet, q=quartet, m=multiplet), coupling constant in Hz, and 
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integration.  Mass spectroscopy data was collected on a HP 5870B GC/MSD mass 
spectrometer with an HP-1 column, and high resolution mass spectrometry was done on a 
Micromass VB-QTOF tandem mass spectrometer. IR spectra were taken on 
FT/IR-410/C031560585 JASCO and Nexus 670 FT-IR E.S.P under neat conditions 
unless and otherwise stated. Melting points were taken on a Uni-melt capillary melting 
point apparatus and Digimelt MPA160 and recorded to a maximum of 270 °C.  For 
products described as waxy solid, melting points could not be obtained. 
tert-Butyl piperazine-1-carboxylate (compound 5): Di-tert-butyl dicarbonate (2.54 
g, 11.6 mmol) in CH2Cl2 (30 mL) was added to a stirring solution of piperazine (2 g, 23.2 
mmol) in CH2Cl2 (60 mL) at room temperature, and stirred for 16 hours. Solvents were 
removed under reduced pressure and the residue dissolved in water (50 mL). The aqueous 
solution was extracted with methylene chloride (4 X 60 mL) and all the organic 
extractions were combined, dried over anhydrous magnesium sulfate and concentrated to 
get tert-butyl piperazine-1-carboxylate (5) as a colorless oil (1.5 g, 8.05 mmol, 34.7% 
based on piperazine); 1H NMR (400 MHz, CDCl3):  3.37 (t, J = 4 Hz, 2 H), 2.79 (t, J = 
4 Hz, 2 H), 1.72 (bs, 1 H), 1.44 (s, 9 H) ppm; 13C NMR (100.6 Hz, CDCl3):  154.3, 79.8, 
45.6, 44.5, 28.8 ppm. 
tert-Butyl 4-(2-bromoacetyl) piperazine-1-carboxylate (compound 6):  
Triethylamine (0.5 mL, 3.5 mmol) was added to a stirring solution of tert-butyl 
piperazine-1-carboxylate (5) (0.60 g, 3.22 mmol) in dry dichloromethane (25 mL) at 0°C 
and stirred for 15 minutes.  Bromoacetyl bromide (0.3 mL, 3.5 mmol) was added 
dropwise at 0°C, and the resulting mixture was stirred at room temperature overnight.  
Reaction progress was monitored by TLC, and after disappearance of the starting 
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material, the mixture was concentrated and purified via column chromatography 
(petroleum ether: ethyl acetate 15-20%) to give tert-butyl 4-(2-bromoacetyl) 
piperazine-1-carboxylate (6) as a white solid (0.8 g, 2.6 mmol, 80.7%): Mp: 95-97 °C.  
1H NMR (400 MHz, CDCl3):  3.85-3.84 (d, J = 4 Hz, 2 H), 3.59-3.57 (t, J = 6 Hz, 2 H), 
3.49-3.48 (m, 4 H), 3.43-3.40 (m, 2 H), 1.45 (s, 9 H); 13C NMR (100 MHz, CDCl3):  
165.7, 154.7, 80.7, 46.8, 42.2, 28.6, 25.8; HRMS Calcd C11H19BrN2O3 307.0657, found 
307.0652 
tert-Butyl 4-(2-(2-nitro-1H-imidazol-1-yl)acetyl)piperazine-1-carboxylate 
(compound 7): Sodium hydride (0.025 g, 1.06 mmol) was added to a stirring solution of 
commercially available 2-nitroimidazole (0.1 g, 0.88 mmol) in dry DMF (1 mL), under a 
N2 atmosphere at 0 °C, and stirred at 0°C for 30 minutes.  At this time, tert-butyl 
4-(2-bromoacetyl) piperazine-1-carboxylate (6, 0.272 g, 0.88 mmol) was added slowly 
and the reaction mixture was stirred at room temperature overnight.  The DMF was 
evaporated and water (5 mL) was added to give a white precipitate, which was filtered 
and dried in vacuo to give an amorphous white powder, identified as tert-butyl 
4-(2-(2-nitro-1H-imidazol-1-yl)acetyl)piperazine-1-carboxylate (7) (0.28 g, 0.83 mmol, 
94.3%). 1H NMR (400 MHz, CDCl3):  7.19-7.18 (d, J = 4 Hz, 1 H), 7.05 (s, 1 H) 5.21 (s, 
2 H), 3.60-3.57 (m, 4 H), 3.50 (m, 2 H), 3.46-3.45 (m, 2 H), 1.46 (s, 9 H); 13C NMR (100 
MHz, CDCl3):  163.4, 154.6, 148.2, 137.4, 121.5, 81.0, 49.0, 45.0, 42.5, 28.6; HRMS 
Calcd C14H22N5O5 340.1621, found 340.1608. 
2-(2-Nitro-1H-imidazol-1-yl)-1-(piperazin-1-yl)ethanone. TFA salt (8): Dropwise 
addition of trifluoroacetic acid (1 mL) to a stirred solution of tert-butyl 
4-(2-(2-nitro-1H-imidazol-1-yl)acetyl)piperazine-1-carboxylate (7, 0.28 g, 0.83 mmol) in 
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dry chloroform (10 mL), was followed by stirring overnight at room temperature.  The 
reaction mixture was concentrated and triturated with ethyl acetate to give 
2-(2-nitro-1H-imidazol-1-yl)-1-(piperazin-1-yl)ethanone, TFA (8) as a white solid, which 
was filtered and dried in vacuo (0.25 g, 0.71 mmol, 85.5%); Mp: 95-96 °C, and used 
without further purification.  1H NMR (400 MHz, D2O)  7.58 (s, 1 H), 7.40 (s, 1 H), 
5.68 (s, 2 H), 4.08 (t, J = 4 Hz, 2 H), 4.03-4.00 (m, 2 H), 3.59 (t, J = 4 Hz, 2 H), 
3.50-3.47 (m, 2 H); 13C NMR (100 MHz, D2O)  166.9, 163.3, 162.9, 162.6, 149.0, 129.2, 
128.4, 121.0, 118.1, 115.2, 112.2, 51.3, 43.3, 42.2, 39.6; HRMS Calcd C10H14F3N5O5 
240.1096, found 240.1149. 
Monosodium(II) 
mono(4-((Z)-2-((2E,4E,6E)-7-(3,3-dimethyl-5-(4-(2-(2-nitro-1H-imidazol-1-yl)acetyl)pip
erazine-1-carbonyl)-1-(4-sulfonatobutyl)-3H-indolium-2-yl)hepta-2,4,6-trienylidene)-3,3-
dimethyl-5-(4-(2-(2-nitro-1H-imidazol-1-yl)acetyl)piperazine-1-carbonyl)indolin-1-yl)bu
tane-1-sulfonate) ( compound 9): A stirred solution of ICG bis(carboxylic acid) 3 (0.2 g, 
0.26 mmol) in dry DMF (2 mL) at 0 °C was treated with 
benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate (PyBOP, 0.30 g, 
0.57 mmol), 1-hydroxybenzotriazole (HOBt, 0.08 g, 0.57 mmol), and 
diisopropylethylamine (DIPEA, 220 µL, 0.57 mmol) in that order, and stirred at 0°C for 
15 minutes.  At this time 2-(2-nitro-1H-imidazol-1-yl)-1-(piperazin-1-yl)ethanone. TFA 
salt (8) (0.204 g, 0.57 mmol) was added and the resulting mixture stirred at room 
temperature for 48 hours.  The DMF was evaporated and the resulting solid was purified 
using C18 reverse phase column chromatography to give (9) as an amorphous green solid 
(0.065 g, 0.054 mmol, 20.7% based on 3). 1H NMR (400 MHz, D2O):  7.84 (t, J = 12 Hz, 
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2 H), 7.57 (s, 2 H), 7.45 (bs, 5 H), 7.35-7.33 (m, 2 H), 7.27 (s, 2 H), 6.57 (t, J = 12 Hz, 2 
H), 6.29 (d, J = 12 Hz, 2H), 5.57-5.51 (m, 4 H), 4.15 (bs, 4 H), 3.86-3.52 (m, 16 H), 2.97 
(t, J = 8 Hz, 4 H), 1.99-1.97 (m, 4 H), 1.91-1.87 (m, 4 H), 1.61 (bs, 12 H); HRMS, Calcd 
protonated formula C55H67N12O14S2 1183.4341, found 1183.4399. 
5.3  Result 
Figure 5-4 shows example fluorescence images obtained by FDOT with mice 
injected with 25  M ICG (a), 25  M ethanolamine-2-nitroimidazole-ICG (b), and 25 
and 15  M piperazine-2-nitroimidazole-ICG (c-d) obtained over 5 to 7 hour period. 
Each image is 9 cm by 9 cm in x and y spatial dimensions at the corresponding target 
depth and the color bar represents the reconstructed dye concentration in  M. ICG was 
completely washed out after 3 hours and the maximum fluorescence concentrations 
obtained from reconstructed images at 1, 15 ,30, 60, 120, 180, and 300 minutes 
post-injection were 0.044, 0.066, 0.078, 0.033, 0.029 0.025, 0.000  M, respectively, 
after subtraction of background value of 0.06  M . However, for targeted conjugates, 
the maximum fluorescence concentrations measured post-injection of 25  M 
ethanolamine-2-nitroimidazole-ICG were 0.028, 0.037, 0.041, 0.037, 0.036, 0.032, 0.026 
and 0.025  M above the background, and that of 25  M 
piperazine-2-nitroimidazole-ICG post-injection were 0.064, 0.131, 0.111, 0.105, 0.072, 
0.061, 0.044 and 0.044  M above the background, obtained at 1,15, 30, 60, 120, 180, 
300 and 420 minutes. The improvement of the second generation dye over the first is 2 to 
3.5 times during the first 3 hour post-injection period and 1.8 times after 3 hour 
post-injection. The maximum fluorescence concentration with 15  M 
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piperazine-2-nitroimidazole-ICG post-injection was approximately 0.040  M higher 
than the background shown in the figure. The ICG fluorescence intensity completely 
washed out after 3 hours, while the targeted piperazine-2-nitroimidazole-ICG had a 
strong residue in the tumor after 7 hours. Figure 5-5 (a)-(d) show the corresponding 
fluorescence images obtained from Odyssey Imaging system of the tumors injected with 
ICG (a), ethanolamine-2-nitroimidazole-ICG (b), and piperazine-2-nitroimidazole-ICG 
(c-d).  The signal intensity with injection of 2-nitroimidazole-ICG conjugates (b-d) is 
substantially higher than that of ICG (a), and the intensity of 
piperazine-2-nitroimidazole-ICG injection is substantially higher than that of 
ethanolamine-2-nitroimidazole-ICG. Two areas of higher and lower fluorescence 
intensity in each image obtained with the Odyssey system were selected for comparison 
to the corresponding tumor hypoxic areas in IHC images revealed with brown staining in 
40x and 400x magnifications (middle column: lower hypoxic areas (e-l), right column: 
higher hypoxic areas (m-t)). Note that, the hypoxia conditions of these four excised tumor 
samples are statistically the same because the sizes of the tumors are similar.26 However, 
the sensitivity or signal intensity of different dye conjugates at different concentrations is 
different and can be seen in these images. Within each image, the higher and lower signal 
intensity areas correspond to higher (more brown stains) and lower (less brown stains) 
hypoxic areas. To quantitatively compare the high and low signal intensity areas within 
each image to hypoxia condition, four windows of size 1×1 mm in the high signal 
intensity areas and four windows of same size in the low intensity areas are chosen and 
the computed percentage of hypoxic areas are shown in the bottom of Figure 5-5. The 
high and low signal intensity areas in each sample correlate with measured high and low 
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hypoxic percentages. In the case of ICG, the signal intensity was too low and the 
quantitatively comparison was .not performed. 
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Figure 5-4 Fluorescence tomography images of four mice obtained over 5-7 hours. (a) 
images of mouse with tumor size of 10 mm injected with ICG and monitored over 5 
hours. (b) images of mouse with tumor size of 8 mm injected with 25  M ethanolamine 
-2-nitroimidazole-ICG and monitored for 7 hours. (c) images of mouse with tumor size of 
8 mm injected with 25  M piperazine-2-nitroimidazole-ICG and monitored for 7 hours. 
(d) images of mouse with tumor size 8 mm injected with 15  M 
piperazine-2-nitroimidazole-ICG and monitored for 7 hours. The time points are marked 
on images. The background value is 0.06  M in all images. 
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Figure 5-5 Top: The corresponding ex-vivo fluorescence images acquired from the 
Odyssey Imaging system of (a) mouse image injected with 25  M ICG. (b) mouse 
image injected with 25  M ethanolamine-2-nitroimidazole-ICG. (c-d) corresponding 
images of two mice injected with 25  M, and 15  M piperazine-2-nitroimidazole-ICG, 
respectively. (e)-(h) corresponding IHC stains (40x, brown ) at low tumor hypoxic area as 
marked at corresponding images, and (m-p) corresponding IHC stains (40x) at higher 
hypoxic area. (i-l) corresponding IHC stains at low hypoxic area ( 400x, brown) and (q-t) 
corresponding stains at higher hypoxic area. Scale bar is 1mm in images. Bottom: 
Percentage of hypoxic area from low fluorescence intensity area (green) and higher 
intensity area (red) of samples (b)-(d). 
Figure 5-6 shows the comparison of average maximum fluorescence concentration 
of three groups of mice injected with ICG (n=2), ethanolamine-2-nitroimidazole-ICG 
(n=2) and piperazine-2-nitroimidazole-ICG (n=3) in 25  M concentration. The 
statistical significance was achieved between piperazine-2-nitroimidazole-ICG and 
ethanolamine-2-nitroimidazole-ICG, and piperazine-2-nitroimidazole-ICG and 
untargeted ICG beyond 60 minutes post injection. The exponential fitting of the washout 
period of each dye is also shown in the figure. This figure demonstrates that the second 
generation dye conjugate had much higher fluorescence signal strength than that of the 
first generation dye. On average, the ratios of fluorescence concentration of 
piperazine-2-nitroimidazole-ICG injected tumors were 2.4 times higher within 3 hour 
post-injection period than that of ethanolamine-2-nitroimidazole-ICG injected tumors, 
and 1.7 times higher beyond 3 hour post-injection. The kinetics of the two conjugates is 
also different. The fluorescence signal from piperazine-2-nitroimidazole-ICG quickly 
reached maximum at 15 minutes post-injection and then declined and remained flat with 
approximately half-life (t1/2) of 6–7 hours. While the signal of 
ethanolamine-2-nitroimidazole-ICG reached maximum at 30 minutes post-injection and 
then slowly reduced and remained flat with approximately t1/2 of 9-10 hours. The 
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fluorescence signal of ICG reached maximum at 30 minutes post-injection and then 
quickly washed out with approximately t1/2 of 30 minutes. For both targeted dye 
conjugates, the optimal window to assess tumor hypoxia is beyond 3 hour post-injection 
when free untargeted ICG is washed out completely. 
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Figure 5-6 Comparison of reconstructed fluorescence concentration (maximum) vs. time 
(minutes) of 25  M ICG, ethanolamine-2-nitroimidazole-ICG and 
piperazine-2-nitroimidazole-ICG with tumor center located at 1.5 cm. The exponential 
fitting of the washout period of each dye is also shown. 
We conducted another set of experiment with three sets of mice injected with ICG 
(n=2), first generation (n=2) and second generation conjugate (n=2) in 50  M 
concentration. On average, the ratios of fluorescence concentration of 
piperazine-2-nitroimidazole-ICG injected tumors were 2.4 times higher within 3 hour 
post-injection period than that of ethanolamine-2-nitroimidazole-ICG injected tumors, 
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and 1.6 times higher beyond 3 hour post-injection. The measured kinetics of each dye 
conjugate is the same as reported above for 25  M injection. 
One experiment was performed by imaging the piperazine-2-nitroimidazole-ICG 
injected mouse 24 hours later to evaluate how long the dye may remain in the tumor. 
Figure 5-7 shows the FDOT images obtained post-injection from one minute to 24 hours. 
The fluorescence signal strength after 3 hour post-injection remains at similar levels. 
Although our observation is limited, this example does suggest that the 
piperazine-2-nitroimidazole-ICG may remain for a longer period of time in the tumor 
which allows for in vivo targeting of tumor hypoxia. 
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Figure 5-7 Fluorescence tomography images of one mouse obtained over 24 hours. The 
mouse with tumor size 10 mm injected with 25  M piperazine-2-nitroimidazole-ICG 
and monitored over 24 hours. The time points are marked on images. 
To further evaluate the sensitivity of piperazine-2-nitroimidazole-ICG, we have 
conducted two sets of experiments with mice injected with 25 (n=3), and 15  M (n=3) 
concentrations and tumors located at 1.5 and 2.0 cm depths, respectively. The average 
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fluorescence signals and the standard deviations are shown in Figure 5-8. For both 
concentrations at both depths, the targeted piperazine-2-nitroimidazole-ICG remains in 
tumor area beyond 3 hours. At a deeper depth of 2 cm, both concentrations yield same 
level of fluorescence signals beyond 3 hours. Thus, the tumor depth did not affect tumor 
imaging. 
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Figure 5-8 Average reconstructed fluorescence concentration (maximum) vs. time 
(minutes) of piperazine-2-nitroimidazole-ICG injection at 25  M and 15  M 
concentration with tumors located at depth of 1.5 cm (blue and red) and 2 cm (black and 
green). 
To quantify the hypoxia conditions of two different groups of mice injected with 
ICG and dye conjugates, light microscopy (40x) images of the IHCsamples were 
analyzed with Image J software. The mean hypoxia percentage for the 
piperazine-2-nitroimidazole-ICG, ethanolamine-2-nitroimidazole-ICG and ICG groups 
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was 2.29% (±0.72), 2.2% (±0.54), 1.98((±0.30), respectively. As expected, there is no 
statistical difference in tumor hypoxia conditions between the three groups indicating the 
tumor model is consistent. However, the tumor size measured from the excised sample 
was found to strongly correlate with the percentage of hypoxia26 as shown in Figure 5-9 
for all tumor samples (Pearson correlation = 0.888, p<0.001). Similarly, the fluorescence 
images from the Odyssey system of the entire tumor sample were also analyzed by the 
Image J software. Figure 5-10 shows the mean fluorescence signals and standard 
deviations of the three sets of mice injected with ICG, first and second generation 
conjugates in 25 (Figure 5-10 (a)) and 50  M (Figure 5-10 (b)) concentrations. In 
Figure 5-10 (a), the mean signal strengths were 3.0 (±0.98), 21.7(±3.82), and 37.7 (±2.22), 
respectively. The signal strength of second generation dye over the first is 1.7 times, and 
the second and first generation dyes over ICG are 12.6 and 7.2 times. In Figure 5-10 (b), 
the mean fluorescence signals are 7.45 (±0.91), 29.6 (±11.38), and 48.6 (±1.55), 
respectively. On average, the fluorescence signal strength of second generation dye over 
the first is 1.6 times, and second and first generation dyes over ICG are 6.5 and 4.0 times, 
respectively. These results from histological sections imaged with the Odyssey Imaging 
system scanner support the in vivo findings. 
5.4  Discussion and Summary 
One method to improve tumor imaging is to improve the bioavailability30, 31 of the 
dye conjugate. A piperazine unit is common in many drugs.31 so we incorporated a 
piperazine linker with the goal of increasing bioavailability32 of the dye conjugate. We do 
not believe that the piperazine per se exhibits any influence on the hypoxia targeting. 
However, if the bioavailability of the dye-conjugate leads to a greater concentration in the 
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tumor, presumably enzymatic reduction of the nitro group will lead to an increased 
concentration of the dye-conjugate. We believe that the observed greater distribution of 
piperazine-2-nitroimidazole-ICG in tissue may be due to the larger number of carbon 
atoms and slightly diminished polarity which increases solubility in tissue when 
compared to the ethanolamine-2-nitroimidazole-ICG. Increased solubility would lead to a 
greater percentage of dye reaching the tumor, along with other tissues, however selective 
hypoxia binding of the dye should lead to a larger percentage of dye-conjugate in the 
tumor relative to other tissues, which would be measured as greater long-lasting 
fluorescence intensity. Indeed we have observed increased fluorescence intensity of 
excised mouse tissues, such as liver and kidney, injected with piperazine ICG as 
compared with the tissues injected with ethanolamine-2-nitroimidazole-ICG, as well as 
enhanced tumor imaging. 
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Figure 5-9 Correlation of measured tumor size vs. percentage hypoxia area for all tumor 
samples (r=0.888, p<0.001) 
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Figure 5-10 (a). The mean fluorescence signals and standard deviations of the three sets 
of mice injected with ICG, ethanolamine-2-nitroimidazole-ICG and 
piperazine-2-nitroimidazole-ICG in 25  M concentrations. The mean signal strengths 
were 3.0(±0.98), 21.7(±3.82) and 37.7 (±2.22), respectively. (b). The mean fluorescence 
signals and standard deviations of the three sets of mice injected with ICG, 
ethanolamine-2-nitroimidazole-ICG and piperazine-2-nitroimidazole-ICG in 50  M 
concentration. The mean fluorescence signals were 7.45(±0.91), 29.6(±11.38), and 
48.6(±1.55), respectively 
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6 Two-step imaging a two-layer tissue structure of 
breast lesions by optical tomography using genetic 
algorithm 
6.1  Introduction 
Diffuse optical tomography (DOT) in near-infrared (NIR) is a promising 
noninvasive approach for functional breast imaging.1-15 However, the resolution and 
lesion localization are poor due to the intense light scattering in tissue, the resolution and 
lesion localization are poor. Additionally, the inverse problem of DOT is ill-posed and 
the solution is not unique. To improve the quantification accuracy of DOT, a proved 
practical method is to provide a priori information provided by a coregistered modality, 
such as MRI, X-ray and ultrasound (US), has been investigated and proved to be a 
practical method for the clinical translation 4, 5, 7-12 With the location information from the 
guidance, the DOT image reconstruction of a suspicious lesion in the semi-infinite turbid 
medium could acquire much higher accuracy. In general, this model is an accurate 
approximation for the reflection geometry when the patient in a supine position. But 
when the breast tissue thickness is less than 2 cm thickness, the contribution from the 
chest wall underneath to the total reflectance measurement could not be ignored. In this 
case, instead of the semi-infinite model, a layered structure instead of the semi-infinite 
model which could estimate the background properties more precisely is needed for 
better reconstruction.16-19 
In our group, we discussed several issues generated by chest wall issue and 
established different models and approaches to solve the inversion problem, such as the 
analytical solution for a two-layer tissue structure with a tilted interface20 and the 
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finite-element method to deal with the reference mismatch problem.21 In this paper, to get 
better estimation of the layered background properties, we introduced a small probe with 
short source-detector distance to calibrate the first layer parameters and then using the 
known values of the first layer to fit the second layer properties. In this way, the unknown 
variables reduced to half and the results were more accurate and robust. In addition, we 
develop a two-step reconstruction using genetic algorithm (GA) and conjugate gradient 
(CG) method to reconstruct the absorption and scattering distributions simultaneously22 
from a two-layer tissue structure. Simulations and phantom experiments are were 
performed to establish the new reconstruction method, and similar clinical examples are 
were applied to validate the real utility of this new imaging method. 
 
6.2  Methodology 
6.2.1 Two-layer tissue model  
Due to the shallow tissue upon the chest wall of the small breast patients in the 
reflectance geometry with a supine position, the chest wall effects for the lesion 
reconstruction could not be ignored. The semi-infinite model cannot produce accurate 
estimation of the lesions for such patients. Therefore, a two-layer tissue model was 
established to fit this need. Figure 6-1 shows the structure of the two-layer model. The 
cylinder with much bigger diameter compared with the lesion was modeled as the 
medium which had two layers of different absorption and scattering coefficients. The first 
layer mimicked the breast tissue of a small breast with less than 2.5 cm in thickness and 
the second layer accorded to the chest wall effect with 7 cm in depth as a semi-infinite 
layer. The lesion was embedded in the first layer. 
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Figure 6-1 The two-layer tissue structure 
6.2.2 Estimation of the background properties  
To estimate the optical properties of the two-layer medium, a 4-parameter 
analytical fitting was developed in our previous work.17 Briefly, by solving the two-layer 
structured diffusion equations, the fluence rate at the tissue surface was related to the 
absorption and scattering coefficients of the two tissue layers: 
)',,',(),( 2211 sasafr   ,                           (1) 
where ),(  r  is the fluence rate, 1a , '1s , 2a  and '2s  are absorption and 
reduced scattering coefficients of the two tissue layers. A nonlinear optimization method 
based on the Nelder-Mead simplex algorithm20, 23 was used to simultaneously fit the 
amplitude and phase to calculate the background properties of the two layers. To improve 
the accuracy of the estimation, we modified this method to a 2-parameter fitting by 
calibrating the 1a  and '1s  of the first layer before fitting using a small probe with 
short source-detector distance (Figure 6-2 (c)). In this way, the first layer properties could 
be concerned as known, so that the variables to be fitted decreased to half ( 2a  and '2s ). 
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Figure 6-2 (a) Experimental setup of the new dual-probe imaging system. (b) and (c) Probe 
geometry used for simulations and phantom experiments. (b) the clinical probe of 1 cm 
thickness and the center slot is used for US transducer. (c) the small probe with short 
source-detector distance used for the estimation of the first layer parameters. 
6.2.3 Two-step inversion with GA  
A two-step reconstruction method using GA was developed for the lesion 
tomography in the semi-infinite medium recently in our previous work. 22 In brief, GA 
was used to obtain the initial properties of the lesions for the reconstruction followed.  
First, an initial population is generated, formed by a certain individuals while each 
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member is a possible solution of the optimization problem and can be represented by a 
vector of real numbers. These individuals then undergo a set of genetic operations ---- 
selection, crossover and mutation ---- in order to promote the population evolution. The 
error of each individual is defined as: 
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where scU  is the measurement, W is the weight matrix and 0a , '0s  are the 
background absorption and reduced scattering coefficients, respectively. The fitness of 
each individual is defined as 1/Er. When the improvement in the fitness of members is 
less than 10-6, or the generation number exceeds 100, the generation of the populations is 
stopped and the select values for the unknown parameters of the model are obtained. 
After that, CG reconstruction method with the initial guess from GA is applied to get the 
absorption and scattering distributions. To adjust this method to two-layer model, the 
weight matrix W in equation (2) is calculated as lvjsidivjA DrrrrGW /),(),( 0  and 
lvksidivkS DrrrrGW /),(),( 0 , where WA and WS  are weight matrices for the 
absorption and scattering, respectively; Dl equals D1 or D2, depending on the voxel 
location in the layered model; rv represents the voxel location, rs is the source position 
and rd is the detector position. In equation (3), 0a , '0s  are modified to 01a , '01s  
and 02a , '02s , which are the background properties for the first and the second layer 
got from the 2-parameter fitting, respectively. After the initial values were obtained from 
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GA, they were applied to the CG reconstruction to get the final tomography for the 
lesion. 
6.2.4 Simulation and experiments  
In simulations, a commercial finite-element (FEM) package COMSOL, which is a 
powerful FEM analysis, solver and simulation software21, 24 was employed to solve the 
forward diffusion equation in frequency domain.21, 25 140 MHz modulation frequency 
was used in all simulations. A cylinder of 20 cm diameter consisted of two layers, the 
first layer was 1.0 to 2.5 cm and the second layer was 7 cm was used to model the 
two-layer tissue medium (Figure 6-1), and 9 sources and 14 detectors were distributed on 
the surface in reflection geometry as shown in Figure 6-2 (b). A 1 cm diameter sphere 
represented the lesion was embedded in the first layer. To calculate the lesion 
perturbation, a corresponding reference data was generated with the same two-layer 
structure but with no target inside. 
In phantom experiments, the frequency domain system we used consisted of 14 
parallel detectors and 4 laser diodes of wavelength 740nm, 780nm, 808nm and 830nm, 
respectively. The experimental setup with the dual-probe system is shown in Figure 6-2 
(a). Each laser diode was sequentially switched to 9 positions on the probe. The central 
slot on the probe shown in Figure 6-2 (b) was used to fit the ultrasound transducer, and 
the sources and detectors were distributed on both sides. Figure 6-2 (c) shows the small 
probe with center source used to estimate the first layer properties. 
To make the two-layer structured phantom, the Indian ink and intralipid solution 
with controlled absorption and scattering coefficients of worked as the first layer were 
controlled by Indian ink and intralipid solution, and soft phantoms were placed under the 
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solution as the second layer. In order to validate the simulations, we tried to make the 
similar conditions for each layer. To control the properties of the first layer, the small 
probe (Figure 6-2 (c)) was merged into a big bottle of the solution to get quick calibration 
and adjust the amount of Indian ink and intralipid until reaching the required absorption 
and scattering coefficients we needed. Phantoms of the second layer were made using 
polyvinyl chloride-plastisol (PVCP) solution, which was a white opaque solution and 
became translucent when it was heated to a high temperature.26 When the solution was 
gradually heated, the Indian ink and titanium dioxide (TiO2) powder were added to 
control the optical absorption and scattering coefficients of the phantom. The heated 
solution was poured into a 10 cm diameter bowl and solidified after cooling for several 
hours. 
Clinical experiments were performed with the system of similar electronic and 
optical design as that used for phantom experiments. The study protocol was approved by 
the local Institution Review Board (IRB) committee. All patients who participated in our 
study signed the informed consent. The patients’ data were taken at the lesion area and 
the contralateral breast of the same quadrant as the lesion. Contralateral data set was used 
to estimate background optical properties for weight matrix computation. The 
perturbation used for imaging reconstruction was computed between lesion data and 
contralateral data and were used for imaging reconstruction. 
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6.3  Results 
6.3.1 Optical property estimation of the two-layer structure  
6.3.1.1 Simulations 
In simulation, the structure showed in Figure 6-1 with two different homogenous 
layers but no target involved was considered as the background. The 2-parameter fitting 
described in section 6.2.2 was used to estimate the optical properties of the second layer 
(The first layer was assumed as known). Three conditions of the first layer and two 
conditions of the second layer (see Table 1) were simulated for 1.0, 1.5, 2.0, 2.5 cm 
thickness of the first layer, respectively. Figure 6-3 shows one fitting example of the first 
layer with 1.5 cm thickness in condition 1 and the second layer in condition 1. We used 
the true value of the first layer as initial value and the fitting results for the second layer 
were a = 0.12 cm−1 and 's = 6.7 cm−1. The fitting accuracy of the second layer in all 
the conditions is listed in Table 1, on average, the fitting error was lower than 5% for a  
and 23% for 's  when the second layer in condition 1 and that was lower than 17% for 
a  and 42% for 's  when the second layer in condition 2, see Figure 6-4. 
 
Table 1 The fitting accuracy of the second layer properties in all the conditions of the 
simulations. 
Second layer (cm−1) 
First layer (cm−1) 
 1) a = 0.1, 's = 6.0 2) a = 0.2, 's = 6.0 
1) a = 0.02, 's = 4.0 a  's  
97.9 % 
76.3 % 
85.0 % 
63.2 % 
2) a = 0.05, 's = 6.0 a  's  
97.5 % 
93.4 % 
86.3 % 
66.1 % 
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3) a = 0.05, 's = 9.0 a  's  
90.0 % 
61.3 % 
77.7 % 
43.4 % 
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(a)                                  (b) 
Figure 6-3 Fitting curves of the second layer properties versus iteration in simulation. (a) 
fitted absorption coefficient versus iteration (b) fitted reduced scattering coefficient  
versus iteration for the second layer with 1.5 cm thick first layer of a = 0.02 cm−1, 's = 
4.0 cm−1. 
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(a)                                (b)   
Figure 6-4 The fitting error bars of the second layer properties versus different thickness of 
the first layer in all condition combinations for the simulations. (a) the fitted absorption 
coefficients (b) the fitted reduced scattering coefficients with the first layer thickness of 1.0, 
1.5, 2.0 and 2.5 cm. The dashed lines are the true values of the fitted properties. 
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6.3.1.2 Phantom experiments 
In phantom experiment, the calibrated intralipid solution (first layer) was poured 
onto the soft phantom (second layer) to construct the two-layer structure and the 
thickness of the first layer was defined by the US image. For better validation, the firs 
layer had the same calibrated properties as the simulation and the two phantoms used for 
the second layer had similar values of a = 0.1 cm−1, 's = 9.0 cm−1 and a = 0.2 cm−1, 
's = 8.0 cm−1, respectively. We tested all the conditions in simulations at all the depths 
from 1.0 cm to 2.5 cm. The results were consistent to our expectation that the thicker of 
the first layer was, the more accurate the estimation of the first layer is more accurate we 
got when the first layer was thicker (Figure 6-5). For instant, for the same combination of 
the first layer of a = 0.02 cm−1, 's = 4.0 cm−1 and the second layer of a = 0.1 cm−1, 
's = 9.0 cm−1, the estimated a  for the first layer were 0.06, 0.05, 0.03 and 0.023 cm−1 
for the thickness of 1.0, 1.5, 2.0 and 2.5 cm, respectively. After the estimation of the first 
layer, the clinical probe with US guided was used to collect the data of the homogenous 
layers. The estimation from the small probe was set as the initial values for the first layer 
and the properties of the second layer could be fitted by the 2-parameter fitting. Figure 
6-6 shows one fitting results for the second layer when the first layer of estimated a = 
0.02 cm−1, 's = 4.0 cm−1 and the true second-layer properties of a = 0.1 cm−1, 's = 
9.0 cm−1. The thickness of the first layer was 1.5 cm. The initial values of the first layer 
from the small probe estimation was a = 0.05 cm−1, 's = 4.1 cm−1 and the fitting 
results for the second layer were a = 0.103 cm−1 and 's = 9.2 cm−1. The fitting 
accuracy of the second layer in all the conditions is listed in Table 2, on average, the 
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fitting error was lower than 15.7% for a  and 37.2% for 's  when the second layer of 
a = 0.1 cm−1, 's = 9.0 cm−1 and that was lower than 8% for a  and 47.9% for 's  
when the second layer of a = 0.2 cm−1, 's = 8.0 cm−1, see Figure 6-7. 
 
Table 2 The fitting accuracy of the second layer properties in all the conditions of the 
phantom experiments. 
Second layer (cm−1) 
First layer (cm−1) 
 1) a = 0.1, 's = 9.0 2) a = 0.2, 's = 8.0
1) a = 0.02, 's = 4.0 a  's  
88.3 % 
75.3 % 
80.0 % 
70.0 % 
2) a = 0.05, 's = 6.0 a  's  
80.0 % 
61.9 % 
83.3 % 
53.8 % 
3) a = 0.05, 's = 9.0 a  's  
73.3 % 
56.9 % 
82.5 % 
64.6 % 
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(a)                                 (b) 
Figure 6-5 The estimated properties of the first layer versus layer thickness. (a) the 
estimated absorption coefficient (b) the estimated reduced scattering coefficient with the 
layer thickness of 1.0, 1.5, 2.0 and 2.5 cm,respectively. The dashed lines are the true 
values of first layer properties. 
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Figure 6-6Fitting curves of the second layer properties versus iteration in phantom 
experiment. (a) fitted absorption coefficient versus iteration (b) fitted reduced scattering 
coefficient versus iteration for the second layer with 1.5 cm thick first layer of a = 0.02 
cm−1, 's = 4.0 cm−1. 
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Figure 6-7 The fitting error bars of the second layer properties versus different thickness of 
the first layer in all condition combinations for phantom experiments. (a) the fitted 
absorption coefficients (b) the fitted reduced scattering coefficients with the first layer 
thickness of 1.0, 1.5, 2.0 and 2.5 cm. The dashed lines are the true values of the fitted 
properties. 
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6.3.2 Lesion imaging using two-step GA reconstruction method  
6.3.2.1 Simulations 
In simulation, the targets of 1.0 cm diameter were located at 1.0 cm center depth in 
the first layer with thickness of 1.5 cm and 2.0 cm.  Since 1.0 cm thickness was too 
shallow to merge the target and the imaging probe together and 2.5 cm thickness was 
deep enough to ignore the chest wall effect, we did not include them into the simulation 
and phantom experiments of lesion imaging.  In this set, we simulated the targets with 
absorption coefficient a = 0.16 cm−1 and different scattering coefficients:  low 's = 
6.0 cm−1 and high 's = 15.0 cm−1, in the two-layer structure with all condition 
combinations listed in Table 1. The fitted maximum absorption and reduced scattering 
coefficients of the targets in all conditions by GA were plotted in . Then these 
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Figure 6-8 The fitted maximum (a) absorption coefficient (b) reduced scattering 
coefficient of the simulated targets located in 1.0 cm center depth using GA in all 
condition combinations of the two-layer structure with 1.5 and 2.0 cm first layer 
thickness. 
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Figure 6-9 simulated (a) absorption (b) reduced scattering coefficient distributions of the 
target with a = 0.1 cm−1 and 's = 6.0 cm−1 located in the 1.0 cm center depth of the 
first layer. The first layer thickness is 1.5 cm and with a = 0.02 cm−1, 's = 4.0 cm−1 
and the second layer is with a = 0.1 cm−1 and 's = 6.0 cm−1. 
fitted parameters were applied as the initial values to the CG based two-layer 
reconstruction method. The target with a = 0.16 cm−1 and 's = 6.0 cm−1 embedded in 
the two-layer medium with the first layer of a = 0.02 cm−1 and 's = 4.0 cm−1 and the 
second layer of a = 0.1 cm−1 and 's = 6.0 cm−1 was taken as an example. The target 
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center depth was 1.0 cm and the thickness of the first layer was 1.5 cm. The fitted initial 
parameters from GA were a = 0.147 cm−1 and 's = 4.86 cm−1 and the reconstructed 
values after CG were a = 0.154 cm−1 (96%) and 's = 6.5 cm−1 (108.3%). The 
absorption and scattering distributions are shown in . On average, the accuracy of the 
reconstructed a  for the targets was higher than 88.3% and that of the reconstructed 
's  was 106% for true 's = 6.0 cm−1 and 76.7% for true 's = 15.0 cm−1. Using the 
new two-layer modeled reconstruction method with GA fitting, we could simultaneously 
reconstruct a  and 's  of the targets with decent accuracy. 
6.3.2.2 Phantom experiments 
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Figure 6-10 The fitted maximum (a) absorption coefficient (b) reduced scattering 
coefficient of the phantom targets located in 1.0 cm center depth using GA in all 
condition combinations of the two-layer structure with 1.5 and 2.0 cm first layer 
thickness. 
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Figure 6-11 (a) coregisted US image. (b) absorption (c) reduced scattering coefficient 
distributions of the target with a = 0.18 cm−1 and 's = 11.0 cm−1 located in the 1.0 cm 
center depth of the first layer in the phantom experiment. The first layer thickness is 1.5 cm 
with a = 0.02 cm−1, 's = 4.0 cm−1 and the second layer is with a = 0.2 cm−1 and 's = 
8.0 cm−1. 
Phantom experiments were performed to validate the simulations. Two targets, one 
with a = 0.18 cm−1 and 's = 11 cm−1 and another one with a = 0.14 cm−1 and 's = 
15 cm−1 were tested in the two-layer turbid medium. Same as simulation, the initial 
values of a  and 's  of the targets were fitted by GA algorithm, and then these 
parameters were applied into the two-layer modeled reconstruction method. The GA 
fitted parameters were shown in .  shows the reconstruction images of an example that 
the target with a = 0.18 cm−1 and 's = 11 cm−1 embedded in a 1.5 cm thick intralipid 
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solution layer of a = 0.02 cm−1 and 's = 4.0 cm−1 with a phantom of a = 0.2 cm−1 
and 's = 8.0 cm−1 as the second layer underneath. The fitted initial parameters from GA 
were a = 0.21 cm−1 and 's = 10.07 cm−1 and the reconstructed values after CG were 
a = 0.204 cm−1 (113%) and 's = 10.38 cm−1 (94.4%).  (a) is the coregistered US 
image, (b) is the target absorption map and (c) is the scattering map. On average, the 
accuracy of the reconstructed a  for the target of a = 0.18 cm−1 was 105.7% and for 
a = 0.14 cm−1 was 95.6%, and that of the reconstructed 's  was 101.5% for true 's = 
11 cm−1 and 108.6% for true 's = 15 cm−1. 
6.3.3 Clinical example  
A clinical example with chest wall effect is given in Figure 6-12. US image of the 
suspicious mass seating on the chest wall marked by the white arrows is shown in Figure 
6-12 (a). The center of the lesion is 1.5 cm and the surface of the chest wall is 2.0 cm in 
depth approximately. First, the small probe was used to estimate the breast tissue (first 
layer) properties, which were a = 0.04 cm−1 and 's = 3.8 cm−1. And then, the properties 
of the chest wall (second layer) were fitted as a = 0.26 cm−1 and 's = 8.8 cm−1. After 
that, using the 2-layered structure and the estimated layer properties as background, the 
initial values of the lesion were fitted by GA, which were a = 0.06 cm−1 and 's = 10.2 
cm−1. Finally, the initial guesses from GA were applied into the CG reconstruction method 
to obtain the absorption and scattering tomography of the lesion in 780 nm, as shown in 
Figure 6-12 (b) and (c). The maximum reconstructed a  is 0.08 cm-1 and 's  is 8.3 cm-1, 
which indicate a benign case.  
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Figure 6-12 A clinical example. (a) coregisted US image. The chest wall is pointed out by 
the white arrows. (b) absorption (c) reduced scattering coefficient distributions of the 
suspicious mass located in the 1.5 cm center depth in780 nm. 
6.4  Discussion and summary 
A new two-step imaging model with the two-layer structure was established to 
improve the reconstruction accuracy of the small breast imaging with the chest wall effect. 
Simulations and the phantom experiments were performed to validate this method and the 
clinical example demonstrated its utility potential. A newly designed dual probe imaging 
system is used to obtain more accurate background properties from the breast tissue and the 
chest wall. A smaller probe with short source-detector distances is used to estimate the 
breast tissue properties (first layer) and then the regular clinical probe is used to acquire the 
data from both breast tissue (first layer) and chest wall (second layer). With the estimated 
first layer properties as known, the second layer properties could be fitted using the 
analytical solution with 2 parameters ( a  and 's  of the second layer). To compare with 
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the previous fitting method from our group, see Ref. 17, 4 parameters ( a  and 's  of the 
first layer and the second layer, respectively) are fitted in the same time from the data 
acquired from the regular clinical probe, the newly dual probe imaging method is faster and 
more accurate. We have an example to show the comparison. A same set of data from 
phantom experiment is used, which has the true values of a = 0.02 cm−1, 's = 7.0 cm−1 
for the first layer and a = 0.1 cm−1, 's = 9.0 cm−1 for the second layer. In Figure 6-13, 
it is showed the fitting results using the previous 4-parameter fitting method. The fitted 
second layer properties are a = 0.11 cm−1 and 's = 4.1 cm−1. The absorption 
coefficient is reasonable but the scattering coefficient is far lower than the true value. 
When the new method is used, the first layer properties was first estimated by the small 
probe, which were a = 0.025 cm−1 and 's = 7.2 cm−1 (see Figure 6-14). Using this 
result as the known parameters, the second layer properties were fitted using the 
2-parameter method as a = 0.11 cm−1 and 's = 9.1 cm−1. It is obvious that the new 
method could obtain much higher fitting accuracy for the scattering coefficient than the 
previous 4-parameter fitting. Additionally, the new method could converge within 70 
iterations and that of the previous method is 250 iterations, which is about 3.5 times 
faster. 
Two concerns in this paper we think are necessary to address here are the first layer 
thickness choosing and the interface distortion between breast tissue and the chest wall 
from the patients. First is the first layer thickness. For our experiment setup, the patients 
are in the supine position, so the breast is squashed by the imaging probe to be closer to 
the chest wall. For the small patients, the breast tissue layer is shallow, thus, the chest 
wall effect cannot be ignored. As the study for the thickness range which the chest wall 
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could affect the estimation of the first layer in Figure 6-5, the conclusion is when the first 
layer thickness is larger than 2.5 cm, no matter how absorbing the second layer is, the 
influence for the first layer is subtle. Therefore, we design the simulation and the 
phantom experiments with the first layer thickness no more than 2 cm. Second is the 
effect of the distortion between these two layers. The interface between the breast tissue 
and the chest wall is not always flat which may introduce some reconstruction error. In 
the Ref. 21, the possible distortion and mismatch were discussed sufficiently. Here, we 
concentrated on the new imaging method and model for the two-layer structure. Thus, we 
did not consider the distortion. In the future real clinical practice, we could simply apply 
the correction into our new two-step imaging model for the cases which needed. 
0 50 100 150 200 250
0.02
0.022
0.024
0.026
0.028
0.03
0.032
0.034
0.036
mua1
0 50 100 150 200 250
6
6.5
7
7.5
8
8.5
9
9.5
mus1
0 50 100 150 200 250
0.05
0.06
0.07
0.08
0.09
0.1
0.11
0.12
mua2
0 50 100 150 200 250
3.5
4
4.5
5
5.5
6
6.5
7
7.5
mus2
(a) (b)
(c) (d)
Iterations Iterations
Iterations Iterations
A
bs
or
pt
io
n 
co
ef
fic
ie
nt
 (c
m
-1
)
A
bs
or
pt
io
n 
co
ef
fic
ie
nt
 (c
m
-1
)
Sc
at
te
rin
g 
co
ef
fic
ie
nt
 (c
m
-1
)
Sc
at
te
rin
g 
co
ef
fic
ie
nt
 (c
m
-1
)
A
bs
or
pt
io
n 
co
ef
fic
ie
nt
 (c
m
-1
)
A
bs
or
pt
io
n 
co
ef
fic
ie
nt
 (c
m
-1
)
Sc
at
te
rin
g 
co
ef
fic
ie
nt
 (c
m
-1
)
Sc
at
te
rin
g 
co
ef
fic
ie
nt
 (c
m
-1
)
A
bs
or
pt
io
n 
co
ef
fic
ie
nt
 (c
m
-1
)
A
bs
or
pt
io
n 
co
ef
fic
ie
nt
 (c
m
-1
)
Sc
at
te
rin
g 
co
ef
fic
ie
nt
 (c
m
-1
)
Sc
at
te
rin
g 
co
ef
fic
ie
nt
 (c
m
-1
)
 
Figure 6-13 The fitted properties of the two-layer versus iteration using the 4-parameter 
analytical solution fitting method. (a) and (c) fitted absorption coefficient versus iteration 
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of the first layer and the second layer, respectively (b) and (d) fitted reduced scattering 
coefficient versus iteration of the first layer and the second layer, respectively. The first 
layer thickness is 1.5 cm. 
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Figure 6-14 The fitted properties of the second layer versus iteration using the true values 
of the first layer. (a) fitted absorption coefficient versus iteration (b) fitted reduced 
scattering coefficient versus iteration for the second layer with 1.5 cm thick first layer of 
a = 0.02 cm−1, 's = 7.0 cm−1 
In summary, a new two-step imaging model is set up for the two-layer tissue 
structure of breast imaging. A dual probe system is used to estimate the background 
properties of the two-layer structure, which could reach higher accuracy. The genetic 
algorithm is applied to fit the initial values of the absorption and reduced scattering 
coefficients of the lesion. After that the conjugate gradient method is used to reconstruct 
the distributions. 
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7 Conclusion 
Breast cancer is the most common cancer and the second major cause of cancer death 
for women. The screening tries to detect the breast cancer in early stage, which could save 
more lives. Diffuse optical tomography (DOT) in near-infrared (NIR) spectrum is a 
promising noninvasive approach for functional diagnostic breast imaging. Our group has 
explored the use of ultrasound (US)-guided DOT to improve the lesion localization and 
light quantification accuracy. In this dissertation, several special cases of breast cancer 
imaging are studied with the US guided DOT technique. 
In the first study,  a series simulation and phantom experiments was performed to 
systemically evaluate the effects of target parameters, target locations, and target optical 
properties on imaging periphery enhancement absorption distribution using reflection 
geometry. Large tumors were modeled as concentric semi-ellipsoidal targets of different 
outer shell and inner core optical properties. We have shown that larger targets of more 
than 3-4 cm diameter with outer shell thickness less than 1 cm can be resolved at depth 
less than 3 cm.  A clinical example is given to show the complex vasculature 
distributions seen from an advanced cancer.   
In the second study, the clustered breast lesions imaging was introduced. Clustered 
small breast lesions may be present in the neighboring areas which are difficult to resolve 
and quantify accurately in diffuse optical tomography. In addition, advanced breast 
cancers are often accompanied by clustered satellite lesions in the neighboring areas, 
which are also difficult to resolve and quantify. To improve the light quantification of 
clustered lesions, a multi-zone reconstruction algorithm guided by co-registered 
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ultrasound image was investigated using simulations and phantoms. The performance of 
the algorithm was demonstrated using clinical examples. This method separated one 
larger region of interest (ROI) into several ROIs based on the location information 
provided by co-registered ultrasound images. In general, the single ROI method cannot 
resolve two smaller targets when their separations were less than 2.5 cm and the target 
depth was greater than 2.0 cm.  The highest reconstruction accuracy using a single ROI 
method was 52% for high contrast small dual targets.  The multi-zone reconstruction 
method with the assistance of co-registered ultrasound improved both the resolving 
ability and reconstruction accuracy.  As a result, two targets located at 2.5 cm depth 
with separation greater than 2.0 cm could be distinguished. With respect to reconstruction 
accuracy at all depths and separations investigated, the multi-zone method reached 91% 
highest accuracy for high contrast small dual targets. 
 In the third study, an US-guided DOT for mapping tumor deoxy-hemoglobin 
(deoxyHb) and oxy-hemoglobin (oxyHb) concentrations in blood phantoms and in in-vivo 
patients was presented. Because oxyHb and deoxyHb respond differently at different 
wavelengths, four laser diodes of wavelengths 740 nm, 780 nm, 808 nm and 830 nm were 
used in the study.  Tumor model experiments were performed using phantoms of different 
hemoglobin oxygen saturations (14% - 89%) representing hemoglobin oxygenation in 
tissue. Targets of different sizes and located at different depths were used to validate the 
accuracy of oxygen saturation estimation. The absolute deviations between the estimated 
hemoglobin oxygen saturations obtained from reconstructed absorption maps and oxygen 
measurements obtained using a pO2 electrode were less than 8% over the measured range 
of oxygen saturation.  An inhomogeneous concentric blood phantom of deoxygenated 
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center core and oxygenated outer shell was imaged and deoxyHb and oxyHb maps 
revealed corresponding distributions which correlated well with inhomogeneous deoxy- 
and oxy- distributions frequently seen in breast cancers.  Clinical examples are given to 
demonstrate the utility of US-guided optical tomography in mapping heterogeneous 
deoxyHb and oxyHb distributions in breast cancers. 
In the fourth study, the synthesis of a 2-nitroimidazole-indocyanine green conjugate 
using a piperazine linker (piperazine-2-nitroimidazole-ICG) capable of robust fluorescent 
imaging of tumor hypoxia was described. In vivo mouse tumor imaging studies were 
completed and demonstrate an improved imaging capability of the new dye relative to an 
earlier version of the dye that was synthesized with an ethanolamine linker 
(ethanolamine-2-nitroimidazole-ICG). Mouse tumors located at imaging depths of 1.5 
and 2.0 cm in a turbid medium were imaged at various time points after intravenous 
injection of the dyes. On average, the reconstructed maximum fluorescence concentration 
of the tumors injected with piperazine-2-nitroimidazole-ICG was two-fold higher than 
that injected with ethanolamine-2-nitroimidazole-ICG within 3 hour post-injection period 
and 1.6-1.7 times higher beyond 3 hour post-injection.  The untargeted bis-carboxylic 
acid ICG completely washed out after 3 hour post-injection.  Thus the optimal window 
to assess tumor hypoxia is beyond 3 hour post-injection.  These findings were supported 
with fluorescence images of histological sections of tumor samples and an 
immunohistochemistry technique for identifying tumor hypoxia.  
In the last study, a two-step imaging model is set up for the two-layer tissue 
structure of breast imaging. First, a small probe with short source-detector pairs is used to 
collect the diffuse light only from the first layer tissue of the regular breast; Then, a 
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clinical imaging probe is used to collect the perturbation data from lesion breast and the 
reference from the contralateral breast.  With the relatively accurate information of the 
first layer, the optical properties of the second layer are fitted. After that, a two-step 
imaging reconstruction using genetic algorithm is performed for the two-layer model 
with the fitted bulk tissue properties. Absorption and scattering distributions of the 
lesions in the layered structure could be reconstructed simultaneously. Simulation and 
phantom experiments show promising accuracy and clinical examples are applied to 
demonstrate the utility of this imaging method. 
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